miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences by Sara dos Santos Teixeira da Silva
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
  
 Sara dos Santos Teixeira da Silva 
 
 
 
 
miRNA as biomarker for body-fluids identification 
Its role in Forensic Sciences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertação de Candidatura ao grau 
de Mestre em Medicina Legal 
submetida ao Instituto de Ciências 
Biomédicas de Abel Salazar da 
Universidade do Porto. 
 
 
Orientador – Doutor Rui Medeiros 
Categoria – Professor associado 
Afiliação – Instituto de Ciências 
Biomédicas Abel Salazar da 
Universidade do Porto. 
 
Co-orientadora – Doutora Ana Luísa 
Teixeira 
Afiliação – Grupo de Oncologia 
Molecular e Patologia Viral, Centro 
Investigação do Instituto Português 
de Oncologia do Porto. 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It is impossible to say how first the idea entered my brain; but once conceived, it 
haunted me day and night 
         Edgar A. Poe 
 
 
 
  
 
 
Acknowledgment  
 
No one should brave the underworld alone. 
Edgar A. Poe 
 
So many persons got my back and give me such support throughout this 
extraordinary chapter in my life. I cannot afford to acknowledge all the surprising 
individuals that were there to help me or motivate me - there is why I do want to 
let you know that I am thankful for making this dissertation possible.  
First, I would like to thank my advisor, Professor Rui Medeiros, for his orientation 
on this project and for the unconditional support he gave me - which greatly 
contributed to the evolution of this dissertation.  
To my co-advisor, Dr. Ana Luisa Teixeira, always present to help me – without a 
shadow of a doubt, a role model to look up to.  
I could not let to mention Professor Maria José Pinto da Costa for being such an 
example.  Thank you for allowing me to do what I really love to do.  
A special thank you to my  Molecular Oncology group, especially to Francisca, for 
help me throughout this essay.  
… 
To my Circle of Friends - Marta, Rosa, Telmo, Luís and Marcos – You guys are 
awesome! We are, without doubt, a hell of a team.  
Vanessa, we started this journey together ten years ago and here we are … 
ending it (for now). You are nuts, you are silly, you are unbelievable and funny as 
hell - You are my CFF – Thank you!  
To Cátia Lopes, Cátia Dias, Joana Vieira and Sissa Oliveira … I miss our time in 
class. We were pretty much crazy together. 
… 
À ma tata, tonton et à mes deux GRANDES sœurs – Vous êtes tout simplement 
incroyables ! 
 
 
Pour les deux personnes les plus importantes dans ma vie, à ma maman et à mon 
papa… 
 Pour tout ce que vous faites pour moi 
 Pour tous ce que je suis grâce à vous  
 Pour tout ce que vous représenté pour moi … 
  
       Thank you 
        Mercie 
          
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 9 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
Table of Contents 
 
 
Abstract ............................................................................................................ 13 
Resumo ............................................................................................................. 17 
1 - Introduction ................................................................................................. 21 
1.1 - Analytical mind .............................................................................................................. 21 
1.2 - Forensic Sciences .......................................................................................................... 22 
1.3 - Evolution of Forensic Science .................................................................................... 22 
1.4 - Forensic Genetics .......................................................................................................... 28 
1.4.1 - Study Case ............................................................................................................... 28 
1.4.2 - Genetic Background ............................................................................................. 30 
1.5 - Importance of body fluids identification ............................................................... 31 
1.5.1 - Blood Identification .............................................................................................. 32 
1.5.2 - Semen Identification ............................................................................................ 34 
1.5.3 - Saliva Identification .............................................................................................. 36 
1.5.4 - Urine Identification ............................................................................................... 38 
1.6 - Genetic approach – a broad confirmatory test? .................................................. 39 
1.6.1 - Potential of RNA .................................................................................................... 40 
2 - Aims ............................................................................................................ 45 
3 - Material and methods ................................................................................... 49 
4 - Chapter 1 ..................................................................................................... 53 
5 - Chapter 2 ..................................................................................................... 81 
6 - General conclusion and future perspectives .................................................. 97 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Abstract 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
 13 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
Abstract 
 
 
In forensic investigation, body fluids represent an important support to 
professionals when detected, collected and correctly identified. Through many 
years, various approaches were used, namely serology-based methodologies 
however, their lack of sensitivity and specificity became difficult to set aside. In 
order to sidetrack the problem, miRNA profiling surged with a real potential to be 
used to identify evidences like urine, blood, menstrual blood, saliva, semen and 
vaginal secretions.  
miRNAs are small RNA structures with 20-25nt whose proprieties makes 
them less prone to degradation processes when compared to mRNA which is 
extremely important once, in a crime scene, biological evidences might be 
exposed to several unfavourable environmental factors.  
First of all, we proceed to an extensive gathering of information published 
till date  and assessed a multitude of factors that have a potential aptitude to 
discrediting miRNA profiling, such as: methodological approaches, environmental 
factors, physiological conditions, gender, pathologies and samples storage.  
Afterwards, we studied 4 miRNAs profiles within 2 body fluids – blood and 
urine – and settled whether or not those could be used as biomarkers for blood 
and urine identification. 
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Resumo 
 
 
Na investigação forense, os fluidos corporais representam um importante 
apoio para os profissionais quando detetados, coletados e corretamente 
identificados. Ao longo dos anos, várias metodologias foram abordadas 
nomeadamente tecnologias assentes em técnicas serológicas, no entanto, a sua 
falta de sensibilidade e especificidade tornou-se uma menos-valia difícil de 
contornar. De forma a dissipar o problema, o estudo dos perfis dos miRNAs 
surgiu com um verdadeiro potencial para identificar evidências tais como urina, 
sangue, sangue menstrual, saliva, sémen e secreções vaginais.  
Os miRNAs são pequenas estruturas de RNA com 20-25nt cujas 
propriedades os torna menos propensos a processos de degradação quando 
comparado ao mRNA, o que é extremamente importante uma vez que, numa cena 
de crime, as evidências biológicas podem estar expostas a vários fatores 
ambientais desfavoráveis. 
Em primeiro lugar, procedeu-se a uma extensa revisão bibliográfica 
publicada até a data e avaliou-se uma variedade de fatores com potencial para 
descreditar o uso de miRNA para a identificação de fluidos biológicos, tais como: 
uso de diferentes metodologias, fatores ambientais, condições fisiológicas, 
género, patologias e acondicionamento de amostras. 
Em seguida, estudou-se o perfil de 4 miRNAs em 2 fluidos corporais - 
sangue e urina – com intuito de concluir se estes poderão ser ou não utilizados 
como biomarcadores para uma identificação fiável de sangue e urina. 
 
 
 
 
 
 
 
 
Palavras-chave: Ciências Forenses, Fluidos Biológicos, Profiling, miRNAs, 
biomarcadores. 
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1 - Introduction 
 
1.1 - Analytical mind 
 
 
It will be found, in fact, that the ingenious are always fanciful, and the truly 
imaginative never otherwise than analytic. 
Edgar A. Poe 
 
 
Edgar Allan Poe, master of gruesome plots, released in 1841 the 
mysterious short-story "The Murders in the Rue Morgue".  Poe created as his main 
character, Auguste Lupin whose, with no other than his mind and incomparable 
confidence, hunted clues using each one of his senses in order to solve 
unsolvable crimes. “The murders in the Rue Morgue” became the first detective 
fiction gender becoming a pillar to other works like Arthur Conan Doyle’s 
Sherlock Holmes. 
Before human behaviour was recognized as an important part in criminal 
investigation, Poe narrated how the body language of a suspect, his accelerated 
heartbeat, rapid breathing and his guilt as a powerful tool to understand 
someone’s blame in a crime. The way he conducted his story, based in analytical 
thinking, “behavioural profiling” and intelligence, led the readers to participate 
alongside with the main character to solve crimes. 
 Edgar Allan Poe’s work projected forensic investigation to a wider public. 
With his books, Poe described the premises of scientific investigation through the 
sharp mind of his main character. Culminating, centuries later, in one of the most 
respected and fascinating science of all.   
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1.2 - Forensic Sciences 
 
 
Even in the grave, all is not lost. 
Edgar A. Poe 
 
 
The term “forensics” is a Latin word that means “belonging to the forum” - 
in ancient Rome, if a criminal case was brought up, it will be brought up before 
the “forum”. Constituted by witnesses and specialists, they will discuss the 
situation with great detail in order to determine guilt in civil or criminal disputes 
and persuade the forum of it [1]. 
Nowadays, forensic science could be defined as the application of a broad 
spectrum of scientific fields responsible for answer questions of interest in a legal 
system whether in civil or criminal actions [2]. Modern forensic science 
investigation, thrived by Locard’s principle - every contact leaves a trace - is 
capable to apply principles but also scientific techniques to analyse evidences 
recovered during a criminal investigation [3, 4]. It is also based on strict 
guidelines in order to ensure cautious and methodical collection, organization 
and analysis of information [5].  
Forensic science can be dissected into several specialized divisions namely 
forensic pathology, anthropology, entomology, odontology, toxicology and 
genetics. Each with its own set of technologies, they contributes to solving crimes 
through investigative activities like determining the cause of death, finding 
missing persons, identifying suspects and profiling criminals [6-13].  
 
 
1.3 - Evolution of Forensic Science 
 
If you run out of ideas follow the road; you'll get there 
Edgar A. Poe 
 
It is commonly though that forensic science is a relatively new science in 
our society. Far behind the glamorous ideology of the 21
th
 century TV series, 
criminal investigation is definitely not such a recent science as it may appear. The 
beginning of Forensic sciences, what we could call - pre-modern forensic science 
1 - Introduction  
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– was not exactly forensic science. Before the 17th century, for the most part of it, 
it was not “real” forensic science, however, some of its background did develop 
on that epoch. By then, for crimes as murder or rape, there would be the 
confrontation of the accuser and whoever is being accused of that crime. The 
suspect would be tortured until its confession - which will ensure its guilt. On the 
other hand, if the suspect was able to resist the pain and have the strength to go 
through the torture it would be considered as innocent [14]. 
A pre-historic drowning of a hand with ridge patterns found in Nova Scotia 
and imprinted fingerprint in clay tablets used for business transactions in ancient 
Babylon, seem to point the origin of dactiloscopy for common use at 1000-2000 
Before Christ [15-17]. Around year 250BC, a Greek physician, Erasistratus, 
observe that his patient pulse rates increased when he lied. His observations were 
considered as what would be the first lie detection test [18]. 
In 44 BC, Antistius, the personal physician of Julius Ceasar, realized the 
first recorded autopsy known. He concluded that even though Ceasar was 
stabbed 23 times, the second blow of the knife – the one that hit his heart – was 
the one that killed him [19, 20].  
On the 3
rd
 century, in China, Yi Yu Ji was published and has some 
semblance of a science applied to criminal cases. One of the cases regarded in 
that publication was of a man that burned to death. His wife claimed that it was 
an accident, however, officials found that there was no ashes in his mouth which 
raised their suspicion. In order to elucidate their doubt, their burned 2 pigs, one 
alive and another already dead. The pig that was alive when burned has ashes in 
his mouth; on the other hand, the pig that was dead did not. Upon this fact, it 
was proven the culpability of the victim’s wife [21]. 
In 1248, still in China, was published the first forensic science book called 
as Hsi Duan Yu (the washing away the wrongs). This book discussed the 
differences between crimes as strangulation versus drowning and became an 
official manuscript for physicians [22-24]. Still that year, a man was stabbed to 
death with a sickle. Sung Tz’u, a medical examiner, gathered everyone in the 
village and had them laid their knives and sickle on the ground and waited. Over 
time, flies came and landed in a particular sickle distinguishing, among others, 
the murder weapon and by association, the perpetuator of the crime [25, 26]. 
The German Constitutio Bambergensis Criminalis, appeared in 1507, that 
highlighted the importance of physicians in cases of infanticides [27]. Also known 
1 - Introduction  
 
 24 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
as the Carolina, it was recognizes as the first criminal law body and punished 
actions as murder, robbery, manslaughter among others [28]. 
The Father of surgery, Ambroise Paré, wrote and published in 1575 
Reports in Court. The French surgeon, already known for his studies on death 
wounds (pre and post mortem), infanticides, hanging, among others, launch 
through his manuscript a new era – The era of modern forensic pathology [29, 
30].  
Hydriotaphia, Urn Burial, wrote by Sir Thomas Browne in 1658 make for 
the first time reference to adipocere [31]. The English physician, also known as a 
pioneering forensic archaeologist, described the unknown process as a soap-like 
substance related with moist places. Although, the term adipocere will only surge 
in 1789 by Antoine François Fourcroy [32]. 
In 1687, Marcello Malpighi noticed the ridges, spirals and loops on 
fingertips, which would become fundamental for human identification [15, 33, 
34]. However he did not acknowledge their function or importance as a mean of 
human identification [34].   
In 1775, the Swedish chemist Carl Wilhem Scheele created a test able to 
detect arsenic poison in corpses [35, 36]. His work would be improved by 
Valentin Rose, who will discover a far more precise method to detect small 
amounts of arsenic [37].  
Three years later, the first recognized documented use of physical 
matching – bullet wound to a suspect - was released in UK.  John Tom was 
convicted for the murder of Edward Culshaw after a wad of paper found in the 
victim wound was complementary with the missing corner of the sheet in the 
possession of the suspect [38].  
In Paris, the former convict Eugène François Vidocq created the first 
detective force in 1810 [39, 40]. The so-called Sureté of Paris was staffed with 
criminals and was specialized in criminal investigation [41]. His work established 
Vidocq as the father of modern criminology [41]. The Vidocq Society, created in 
honor of Vidocq is composed by forensic professionals and private citizens who 
directed their work to solve cold cases [42]. 
1813 unveiled one of the most important individual in forensic toxicology 
– Mathieu Orfila [43]. Considered as the father of modern toxicology, Orfila 
published Traité des poisons which was the first report on poison detection and 
started to be used as a guideline for murder cases [44].  
1 - Introduction  
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In 1828, William Nicol invented the polarized light microscope that led 
Henri-Louis Bayard in 1839 to formulate the first procedures for microscopic 
detection of sperm [45-47].  Later that year, James Marsh, a Scottish Chemist, was 
the first person to testify using toxicological evidences in a criminal trial [22, 48, 
49]. That is when we start to see the merging between science and law - which is 
the principle of forensic science.   
1850s to 1860s settled for a development of photography which improved 
records in forensic science more specifically in prison system [50].  
In 1879, the French anthropologist Alphonse Bertillon introduced the 
Bertillon system which is also known as anthropometry [51]. He used a large 
amount of measurements of the body to identify people by their physical 
appearance [52, 53].  However, this worked relatively well until a particular case – 
the Will West case – put it to an end (figure 1). In 1903, a man called Will West 
was put in prison. The person who was processing him asked if Will West had 
already spent time in prison before which he answered negatively. The clerk went 
to the record and founds out that there was another person in that prison by the 
name of William West that looked nearly identical. When put in the Bertillon 
system, their measurements were also practically identical. This coincidence put 
an end to the commonly used method of identification [54-56].  
 
Hans Gross, in 1893, published Criminal Investigation that discussed the 
benefits of botany, chemistry, fingerprinting, geology, microscopy, physics and 
zoology in criminal investigations [57, 58].  
The Nobel Prize winner Karl Landsteiner discovered in 1901 human blood 
groups which would be adapted later on by Max Richter for blood stains typing 
[59-62].  
Figure 1 – The West Case - Photographs of both Will and William West displaying their 
undeniable resemblance.  
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The American President, Theodore Roosevelt, established in 1905 the 
Federal Bureau of Investigation (FBI) whereas FBI director J. Edgar Hoover opens 
the FBI laboratory in 1934 [63, 64]. 
In 1910, Albert Osborn published Questioned Documents which is still a 
reference when determining document forgeries [65, 66].  
Another important personality in the forensic field is Edmond Locard. 
Between 1877 and 1966 the French doctor and criminologist opened the very first 
crime laboratory in France but most importantly, he created the Locard’s 
Exchange principle. Basically, this principle relies on the fact that anytime 2 
things make contact, there is an exchange of material [67, 68]. There was a case 
involving possible forged coins that had 3 suspects. Locard asked to see the 
suspect’s clothes that they were wearing when arrested and was able to find small 
metal fragments on them. Locard match those metal fragments to the forged 
coins resulting in the condemnation of the suspects [69].  
The American chemist Walter McCrone, between 1916-2002, was the 
leading expert in microscopy and was the one asked to examined the famous 
Shroud of Turin and the Vinland map [70-72].  
In 1990, the FBI created its personal database of genetic profiles from 
convicted criminals and those associated with unsolved crimes. Named Combined 
DNA Index System – CODIS – the program constitute a real step forward in 
forensic genetic field (figure 2) [48, 73].   
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Figure 2 – Timeline of the major developments in forensic genetics. 
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1.4 - Forensic Genetics 
 
Invisible things are the only realities 
Edgar A. Poe 
1.4.1 - Study Case 
 
In 1987, days after Thanksgiving, the detective Joe Horgas was on duty 
when he received a call for a homicide case in Arlington suburb, outside 
Washington D.C.  He and the other officers proceeded through the house and 
found the dead body of the 44 years old Susan Tucker laid face down on the bed 
of the master bedroom. Naked with just a blue sleeping bag next to her, she had 
her hands tied behind her back with a brand-new rope going from her hands up 
to her neck. By the time of the murder, Susan’s husband was in Great Britain 
visiting his family in Wales, where the couple has been planning to move. Agent 
John Coale and Rick Schoembs from Arlington County police department 
investigate the crime scene and documented it with close-up photography. On the 
floor nearby, an empty purse with its content scattered on the floor. The officers 
zeroed-in what they thought to be the point of entry of the assailant. Outside of 
the house there was a patio and just beneath it a narrow basement window that 
was found broken.  The officers collected all the broken glass they could find. It is 
important to acknowledge that there is always a transfer of material between 2 
objects – Locard’s Exchange principle. If the assailant did entry the house by that 
window, the glass would present some kind of evidence occasioned by an 
exchange of assailant-glass material.  
Curiously, a similar murder occurred 3 years earlier. Carolyn Hamm was 
raped and murdered only 3 blocks away from Susan Tucker’s house.  Just as 
Susan Tucker case, the assailer entered her house by a narrow opening and the 
content of her purse was scattered on the floor yet nothing of value was missing. 
Because of it, Joe Horgas pulled the Carolyn Hamm file in order to get leads to his 
case. Carolyn Hamm’s file was closed, a man was convicted for her murder and 
already behind bars but doubts still remained. Everyone who worked in the case 
didn’t believe that the suspect – David Vasquez – was responsible for the crime or 
at least, it was not the only responsible. David Vasquez was serving 34 years of 
reclusion, he plead guilty in order to avoid death penalty. Then, 3 years later, the 
same exact crime happened. Detective Joe Horgas believed that the perpetuator 
of Carolyn Hamm’s murder was the same of Susan Tucker’s. Despite the 
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similarities, Horgas had no leads and any fingerprints were found.  However, 
Horgas had hopes for the other evidences.  Once in the laboratory, the blue 
sleeping bag, Susan’s nightgown and a washcloth with smears on it were 
analysed and it was found 4 different stains just in the nightgown. They tested 
them with acid phosphatase and the purple colour indicated the presence of 
semen but to confirm it, a small portion of the stain was examined 
microscopically. After positively identified, remained the questions: to whom it 
belongs? In 1987 the only way to connect semen to a rapist was, first of all, by 
determining if any blood was present in it. Is so, the blood could be typed.   In 
that case, the blood type was O and matched neither the victim nor her husband. 
The results narrow down the field of possible suspects, however, the stained 
washcloth held an additional piece of the puzzle – 2 pubic hairs. The pigments 
granules analysis enabled the determination of the race of the suspect and in that 
case, the pubic hair came from a black man.  
At the same time, in Richmond (2 hours from Harlington), a serial murderer 
known as the South Side strangler was on the loose. Responsible for the rape and 
murder of 3 women within the preceding 3 month, could the South Side strangler 
be responsible for the murders in Arlington? Detective Horgas went to Richmond 
to compare notes and the similarities were impressive.  All 3 victims were tied-up 
and strangled but most importantly, in all cases, the assailant entered by the 
window. Later, lab tests confirmed that the semen stains found in the 3 murders 
were identical in blood type to those found in Susan Tucker’s nightgown. 
However, a common blood type is hardly enough to implicate a killer.  
In 1987, Deoxyribonucleic acid (DNA) testing was not widely used in 
forensic labs. Detective Horgas sent the semen stains found in the nightgown of 
Susan Tucker to a laboratory in New York. Richmond police also submitted semen 
samples from the 3 murders.  Back then, the process had a limited sensitivity, it 
was required a large amount of biologic sample and its analytic study could take 
to 6-8 weeks.  
Due to the gap of 3 years between the murders, detective Horgas 
concluded that the suspect had probably been in prison and searched for 
someone who got arrested after Carolyn’s murder and got released sometime in 
1987.  Taking this into account, Timothy Spencer became a suspect. Released of 
prison in 1987, he went to a halfway house in Richmond 2 weeks before the first 
crime.  
1 - Introduction  
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On January 20
th
 1988, Timothy Spencer was arrested. At the time they had 
little evidence - just the remains of glass from the broken window. After his arrest 
the police went to his room in the halfway house where they found his pants, ski 
mask and an army jacket. Lab tests were conducted in a small piece of glass 
found in the suspect jacket and compared to the shards of the broken window of 
Susan Tucker’s house. Even if both had the same optical proprieties, this evidence 
was not enough to convict the suspect because the glass was not unique enough 
to distinguish it from hundreds of other windows.  The only physical evidence 
that could link Timothy Spencer to the crime was DNA.  
After his arrest, a sample of his blood was taken and his DNA profile was 
drawn. Four months after the murder of Susan Tucker, the results were 
completed – the DNA from the crime scene matched with the Timothy Spencer’s 
DNA. In July 1988, Timothy Spencer trial begun and condemned him to death 
penalty. In 1989, David Vasquez received a pardon and was released.    
This case was the first to convict a suspect of a capital murder in the 
United States based on DNA profiling [74-76].  
 
1.4.2 - Genetic Background 
 
Every living organism has their own individual DNA and its singularity 
allows us to distinguish humans from animals or even plants [77]. Most 
importantly, due to the different combinations of DNA sequences, the study of 
each “genetic prints” allows an individual identification among humans [77, 78].  
DNA can be found in humans cells, namely in blood, hair and sperm – that 
are also the most commonly samples found in crime scenes [5]. After correctly 
collected and analysed, it is possible to determine a DNA profile allowing 
individual identifications [78].    
In order to create a genetic profile, a certain amount of genetic material is 
required. The genetic material can be easily found however, adverse conditions as 
heat, pH, drought, among others can present negative effects and deteriorate the 
samples preventing its analysis and posterior DNA profiling [79].  In a crime 
scenario, after evidences collection, it is necessary to gather samples from the 
suspects in order to compare both genetic profiles and conclude whether or not 
the suspects are linked to the crime. Nevertheless, the genetic profile needs to be 
compared with the victim DNA in order to remove the possibility that the 
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“suspect” DNA was the one provided by the victim. After processed, the 
information needs to be interpreted. If both evidence and suspect sample 
profiling matches, it is required to determine the probability that the profiles 
correspond with another profile in random population [80].  
This way, the use of DNA profiling in criminal investigation can bring 
benefits to the society by helping to solve crimes, exonerate innocents and 
assisting in the enforcement of the rule of law. 
 
 
1.5 - Importance of body fluids identification 
 
Believe only half of what you see and nothing that you hear. 
Edgar A. Poe 
 
Serological test allows the detection and identification of body fluids in 
both native form or as a residue left at a crime scene [15]. Items on which body 
fluids are thought to be present are submitted to laboratories for serological test 
and DNA analysis [81]. Before any analysis, it is needed to choose whether the 
items go through serological test or if they are sent directly for DNA analysis [82]. 
Indeed, each body fluid requires a different molecular methodology in order to 
get a more reliable product to conduct a DNA analysis. For example, DNA 
extraction processes are different for blood and urine. If we conducted the 
protocol of blood extraction in urine samples it may result in a reduced quality of 
the isolated DNA, which can compromise the DNA analysis [77, 82]. 
If fresh blood is fairly easy to identify, bloodstains on grass changes colour 
quickly, making difficult its identification [82]. Though, this process happens with 
other biological evidence such as seminal fluid, urine, saliva and so on, when 
dried or washed.  It is why all evidence goes through serological screening first in 
order to reliably identify the item and ultimately proceed to the molecular process 
to obtain the most high-quality sample possible. However, samples with trace 
amounts of DNA goes straight to DNA analysis [79, 82].  
Whereas the majority of cases processed involved violent crimes there is 
been an increase of cases involving DNA to assist in solving property crimes. 
1 - Introduction  
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Biological evidences are usually left by the burglar. For example, a burglar may 
injure himself and leave blood at the crime scene or, as an act of vandalism, can 
relieve himself on the items of the house [48, 83]. 
As a matter of fact, a complainant’s body fluid present on items belonging 
to a suspect - or vice-versa - holds the most probative value [15]. For example, in 
cases of sexual assaults, the detection and identification of semen from a sexual 
assault kit is crucial to support a claim of the same purpose.   
In order to be sure, the identification of body fluids through serological 
analysis is accomplished through presumptive and confirmatory tests. 
Presumptive tests rely on methodologies that are sensitive and performed 
quickly, yet they are not specific to the body fluid. Those tests can only indicate if 
the fluids might be present and do not unequivocally states its presence [77].  On 
the other hand, confirmatory tests are indeed specific to the body fluid we seek 
to identify. As presumptive tests, confirmatory testing is sensitive however, it 
takes a lot more time [77].  
 
1.5.1 - Blood Identification 
 
A comatose teenage female was discovered to be pregnant and the suspected 
father was no other than a juvenile friend of the victim’s brother. In order to 
elucidate whose the father was, the aborted fetus was submitted along with the 
victim’s and suspect’s blood for a paternity test. Blood samples from the victim’s 
brother and father were also submitted. To the general surprise, the suspect was 
excluded as the father of the fetus, however the results showed that the brother 
was the one who fathered the fetus. 
Adapted from Fisher et al. [84]. 
 
The identification of blood can be key-evidence in a wide range of possible 
situations. Blood identification is essential to many homicide investigations but 
also in cases involving aggravated assaults, burglary and sexual assaults [85]. 
The presence of blood can support the complainant’s or suspect’s version of 
alleged events establishing culpability or innocence during a criminal proceeding.  
Before an extensive blood loss, its detection may not be difficult. However, 
in some cases where only a very small amount of blood is transferred, its 
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detection may be very complicated.  In cases where the crime scene is been 
cleaned-up and no blood is visible to the naked eye it is important to rely on 
serological tests that could allow us to detect and reliably identify blood from 
clothing, floors, grass or any other surface. 
The bright red distinctive colour of blood is derived from haemoglobin. 
Yet, when it dries, the colour darkens to red-brown and finally to brown, which 
can difficult its detection and identification.  
When an unknown stain is found at a crime scene, the first process we 
need to use is the so-called presumptive tests. Those tests usually help to 
elucidate some important questions as:  is it blood? or Is it human blood? [86]. 
Idealistically, presumptive test must always be supported with confirmatory 
testing (figure 3). 
Till date, there are 3 main presumptive tests for blood:  Phenolphthalein, 
Tetramethylbenzidine and Luminol test [15].  
Phenolphthalein test, also known as Kastel Meyer test, is the most 
frequently used presumptive test for blood [87, 88]. When the chemicals are 
added, they will react with the haemoglobin present in blood causing the 
formation of a bright pink colour within 10 to 20 seconds [89]. As its main 
advantage, this particular technique is very sensitive and highlights stains that 
are barely visible or even imperceptible to the naked eye [87, 90]. As the others 
presumptive tests, this particular one does have a major disadvantage – it can 
easily create false positives once, substance like rust, cooper, among others can 
also react resulting in a bright pink colour [87].  
Tetramethylbenzidine test works the same way as Kastel Meyer, but in this 
particular case it turns into a blue-green colour instead of a bright pink dye [87, 
91]. When compared, tetramethylbenzidine test present a greater level of 
specificity yet, it does not work as well in diluted blood stains, which is a 
substantial and important limitation[91].  
When blood is suspected to be present but invisible to the naked eye, it 
would not be reasonable to test the whole item on which the stain may be 
present. In such occasions, luminol testing is used to indicate nonvisible blood 
stains [15]. Instead of producing colour change reactions, this chemical 
presumptive test leads stained areas to emit light [86].  This test is particularly 
sensitive – even more that the 2 precedent tests previously referred  [15]. One 
disadvantage attached to this test is the same verified with the phenolphthalein 
test, the occurrence of  false positives [67]. In addition to those already named 
1 - Introduction  
 
 34 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
previously, it also react with bleach and others cleaning fluids which is a problem 
once it may interfere and create false results on surfaces that have been cleaned 
[92].  Moreover, when we spray a stain with the chemical, it dilutes the stain. In 
cases where the stain is already weak, its further dilution may lessen the chances 
of obtaining a good DNA profile which is another significant drawback to that 
test. 
 Nowadays, the Rapid Stain Detection of human blood (RSID™-blood) and 
the ABAcard® are the most commonly used confirmatory tests in forensic 
laboratories [87]. Rapid Stain Detection kit enables blood identification through 
the detection of human glycophorin A, which is present in erythrocytes 
membrane [73]. Likewise, ABAcard® kit it is very similar to the precedent but 
detects the presence of human haemoglobin instead of glycophorin A [73, 85].  
  
 
 
 
 
 
1.5.2 - Semen Identification 
 
Before the complaint of a sexual assault to a child, a DNA profile was recovered 
from samples taken from a child’s underwear and bedding. His step-father, 
considered as suspect in this case, argued that the source of DNA was recovered 
from his skin cells deposited from a casual and frequent contact with the clothes 
and beddings of the child. For instance, if serological tests were done, in order to 
elucidate from which tissue the DNA was recovered, and concluded that his DNA 
was originated from semen and not from skin cells, those results would definitely 
plays a key-role to support the allegation of sexual assault. 
 
Semen is an extremely important body fluid in cases of sexual assaults 
[91]. As for example, the identification of semen on vaginal smears swabs or on a 
victim’s clothing may be of value in corroborating the victim’s claims.  
Figure 3 - Presumptive and confirmatory tests for blood. Representation of: A- Phenolphthalein test. B- 
Tetramethylbenzidine test. C- Luminol testing; D- Device used for both ABAcard® and RSID™-blood confirmatory tests. 
A B C D 
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It is important to underline that not all men produce spermatozoa. Some 
who have birth defects, have had a vasectomy or as the result of a disease either 
do not contain or contain very few spermatozoa in their seminal fluid [87]. For 
that reason, in forensics, 2 major components of semen are particularly 
important for its identification: seminal fluid and spermatozoa [87].   
 The most frequently used presumptive test for the detection and 
identification of seminal fluid relies on the detection of the enzyme acid 
phosphatase (figure 4) [93]. This enzyme, present in seminal fluid, is also present 
in others body fluids such as urine, saliva or vaginal secretion yet, in lowest 
concentrations [87].  The internal concentration of the enzyme allows it be used 
as a presumptive test for seminal fluid identification, however, its presence in 
other body fluids leads to a tricky complication: false positives. Acid phosphatase 
is identified using the brentamine spot test which alters the colour of the tested 
area into a bright purple colour in a positive case [15, 91]. The absence of colour 
change not only may indicate that no seminal fluid is present but also may 
indicate that the level of the enzyme is lower than the detection limit of the test.  
This is the reason why, when this methodology is used, it is indeed necessary to 
use additional  tests to confirm the presence or absence of seminal fluid [15]. 
It wouldn’t be reasonable to test a large item with the acid phosphatase 
test to detect nonvisible stains. In order to visualise those stains, an alternate 
light source is used to pre-screen the item and detect areas that could be 
processed for acid phosphatase detection (figure 4) [87]. However, not only 
semen does fluoresce when exited with alternate light but other like saliva or 
urine does too - hindering its reliability [15]. 
Items that have been tested presumptively positive can be confirmed by 2 
different processes: either by a chemical detection of a specific protein of semen 
or through a microscopic detection of spermatozoa (figure 4) [48, 87].  
Identify spermatozoa microscopically is an undeniable proof that semen 
was present in the analysed item. Positively tested swabs can be smeared onto a 
microscope slide and stained by what is commonly called the Christmas tree stain 
[87]. Composed by two different dyes – nuclear fast red (red colour) and 
picroindigocarmine (green colour) it enables the visualization of spermatozoa. 
The head of the spermatozoa will turn red while the tail, if present, will turn 
green - hence the name of Christmas tree [48, 87]. Nonetheless, seminal fluid 
belonging to a vasectomise individual does not have spermatozoa therefore, in 
this situation, microscopic methods do not allows the identification of seminal 
1 - Introduction  
 
 36 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
fluid [15].  Moreover, the time necessary to microscopically analyse the items is 
considerable - representing an undeniable drawback when compared to the 
protein confirmation method. 
The protein confirmation method can be done through the Rapid Stain 
Detection (RSID™-semen). Rapid Stain Detection kit enables semen identification 
through the detection of prostate-specific antigens (PSA) and when tested 
positive, serves as an undeniable confirmatory test for semen [87].  
 
 
 
 
 
 
 
1.5.3 - Saliva Identification 
 
An executive in a major company received threat letters and suspected one of his 
employees who also had an affair with his wife. Though, no arrest or search 
warrant was up due to the lack of evidence.  Later, the chief of the police received 
a mailed bomb coupled with a threat letter. The saliva present on both treat 
letters were subjected to a DNA typing and finally compared to the saliva residue 
found in love letters that the suspect sent to the executive’s wife. The DNA types 
matched and were enough for a search warrant for a sample of blood of the 
suspect. After confirmation, the suspect was charged with attempted of murder. 
Adapted from Fisher et al.[84].  
 
Secreted by the parotid, sublingual, submandibular salivary glands and the 
mucous glands of the oral cavity, saliva is responsible to keep the mucous 
membrane moist. It is also responsible for salivary digestion of carbohydrates 
once the saliva principal component, α-amylase, convert starch into maltose [94].  
The transfer of such material can be resulting of direct contact as in food 
when eating, cigarette butts, straws, drink vessels, envelopes, stamps, bite marks 
or in cases of oral sex assaults. On the other hand, saliva gathered from an object 
B 
 
C D A 
Figure 4 - Presumptive and confirmatory tests for semen. Representation of: A- alternate light source test; B- Acid 
phosphatase test; C- Christmas tree stain; D- RSID™-semen confirmatory test. 
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as a telephone – mouth piece - result of projected biological material, is a good 
example of indirect transfer [77].  
Currently, saliva screening is mainly done through presumptive tests 
(figure 6) [95]. Alternate light can be used as a tool for saliva identification, 
usually in cases where biological fluid are searched in clothing [96]. When excited 
with alternate light, saliva fluorescence highlights its presence among other 
biologic samples [96, 97]. However, there is a pretty obvious limitation to that 
test. Just like saliva, seminal fluid also responds to alternate light resulting in 
fluorescence (figure 5) [87]. To that point, if the laboratory analyst knows where 
to look, the problem dimension can be reduced - increasing the probability that 
the fluorescent stain is connected with saliva. Nonetheless, if it goes the other 
way and the analyst does not know what he is looking for, he will face a major 
problem – he will not be able to identify any saliva stains.  Due to the fact that 
many other fluids  or even substances can fluorescent with alternate light, this 
presumptive test is used only to identify areas for additional examinations 
through other screening tests. 
 
 
 
 
 
 
 
 
Another set of presumptive test for saliva and currently the most widely 
used is based on amylase detection which is an enzyme that is found at high 
levels in saliva. The Phadebas® test is used in forensics to identify stains 
containing amylase and it is performed using paper impregnated with a reagent 
that dissolves into the paper releasing a blue dye when contacting with amylase 
[98, 99]. As any other presumptive test, there is some serious limitation to the 
methodology – Phadebas® test does not differentiate human saliva from other 
species and, as it was referred before, amylase can be found in other fluids other 
than saliva and thus this test can identify stains that are not saliva. In order to 
sidetrack the problem related with species, another presumptive test called Rapid 
Stain Detection for saliva (RSID™-saliva) was released [100]. RSID™ test, unlike 
Phadebas®, only recognize human α-amylase [101]. 
Figure 5- Stains detected by alternate light source – this 
presumptive test allows the detection of saliva however, other 
body-fluids do also shows.  
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To our knowledge, there is no confirmatory test for saliva identification. 
However, some laboratories choose to run all 3 tests in order to increase the 
probability to reliably identify human saliva.  
 
 
 
 
 
 
 
 
1.5.4 - Urine Identification 
 
Two young brothers accused their neighbour of child molestation, claiming 
that he gave them pills in order to make them dozy. Blood and urine of both kids 
were collected for a toxicological screening. Before negative results, the children 
confessed that they made-up the entire story because they did not like their 
neighbour. 
Adapted from Fisher et al. [84]. 
 
The urinating act is commonly found as an act of vandalism and, when 
gathered, urine can be a source of trace DNA [48]. However, this body fluid is 
found to be particularly good for drug screening, especially drugs of abuse once 
nearly all drugs are eliminated in it [48, 102]. 
 There are several simple and fast presumptive tests for urine. The oldest 
test is undeniably related with its characteristic colour and odour [82]. A simple 
heating of the samples can emphasise the odour and help with the identification 
process [82].  
The easiest presumptive test is a chemical test named Jaffe colour test. 
This test is based on the detection of creatinine through the formation of 
creatinine picrate. A drop of water extracted from the putative stain is mixed with 
a drop of saturated picric acid followed by a drop of 5% NaOH. The apparition of a 
bright orange colour indicates the presence of creatinine [82, 103].   
Another presumptive test relies on the detection of the major component 
of dried urine - urea. In the presence of the enzyme urease, urea is cleaved and 
A 
B C 
Figure 6 - Presumptive and confirmatory tests for saliva. Representation of: A- alternate light 
source test; B- Phadebas® test; C- RSID™-saliva. 
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formed ammonia which can be easily detected by bromothymol blue. This 
mapping process uses large sheets of dampened filter paper that allows urine 
stains to be located when the paper turns bright blue [104]. Due to the limitations 
associated with those presumptive tests, it is essential to develop more sensitive 
and specific methodologies.  
 
 
1.6 - Genetic approach – a broad confirmatory test? 
 
 
Experience has shown, and a true philosophy will always show, that a vast, 
perhaps the larger, portion of truth arises from the seemingly irrelevant. 
Edgar A. Poe 
 
 As previously stated, from a  forensic point of view, body-fluids 
identification are crucial for evidential value but also to guarantee an accurate 
handling of samples, culminating in a reliable DNA profiling. As it is evidenced, 
there are a lot of presumptive tests available however, confirmatory tests are way 
scarcer or simply inexistent. If the reliability of results depends primarily from a 
correct identification of a certain body fluid, can we really relies ourselves on 
presumptive tests? 
Fact is, for some body fluids like menstrual blood, there is no confirmatory 
test drawn-up till date. Forensically speaking, there is no shadow of a doubt that 
menstrual blood is important. If we focus on a sexual crime complain, the 
presence of blood or menstrual blood in the victim’s underwear do not have the 
same impact. Quite the contrary, a correct identification of the stain could be 
considered as a major evidence to blame or exonerate the suspect.  
Currently, we stand in a molecular epoch where everything seems to find 
its explication and resolve through a DNA approach. Following this line of 
thought, it would be reasonable to believe that the ultimate confirmatory test 
would be based in our genetic background.  
If DNA profiling allows the identification of individuals through their 
respective DNA signatures, it does not identify the type and source of the 
evidence. Its lack of distinctive signature for each type of body tissue withdraw 
DNA profiling as a possible candidate as a confirmatory test.   
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Looking closely at the central dogma of molecular biology, DNA is 
transcribed into RNA which is translated in protein. Interestingly, RNA does have 
a specific pattern related to the tissue source. Facing that, is it reasonable to 
believe that RNA could be a key-factor to answer the dilemma? 
 
 
1.6.1 - Potential of RNA 
 
Different cell types present in body fluids have different functions and 
thus, they require a different cluster of functional proteins [105, 106]. Once 
messenger ribonucleic acid (mRNA) is responsible for the translation of DNA 
genetic code into proteins, it is logical to consider that different cell types have 
also a different mRNA pattern expression.  
Advantages linked to mRNA profiling are undeniable. It has a great 
specificity, for example, for any tissue we choose, we are able to find mRNAs that 
are tissue specific [107]. It is also possible to simultaneously analyse a multitude 
of markers through common assays. Decreased sample consumption, co-
extraction of both DNA and RNA and the automation of the laboratorial 
procedures are a serious improvement that enhances this methodology [108].  
 Some important results were published from precedent reports as it is 
shown on table 1.   
 
Table 1 – overview of some mRNA published as biomarkers for body fluids. 
 mRNA REFERENCES 
BLOOD beta-spectrin (sptb) [109] 
 porphobilinogen deaminase (pbgd) [109] 
 aminolevulinate synthase (alas2) [110] 
   
SALIVA statherin (stath) [107, 109, 110] 
 histatin 3 (htn3) [107, 109, 110] 
 mucin 7 (muc7) [110] 
   
SEMEN protamine 1 (prm1) [109, 110] 
 protamine 2 (prm2) [107, 109, 110] 
   
VAGINAL 
SECRETIONS 
human beta-defensin 1 (hbd-1) [109, 110] 
mucin 4 (muc4) [107, 109, 110] 
keratin 16 (krt16) [107] 
   
MENSTRUAL 
BLOOD 
matrix metalloproteinase (mmp) 7, 10, 11 [107, 110] 
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Despite the accomplishment of mRNA profiling, mRNA susceptibility to 
degradation by physical or chemical factors has always been problematic [111]. 
The use of RNA presents itself with great potential. Theoretically, mRNA 
seems to be reliable as a confirmatory test however, its susceptibility is a major 
impediment. That is why forensic researchers decided to look towards the most 
studied RNA structure in the past few years: miRNA.
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2 - Aims 
 
 
The aim of the present work was to study miRNA profiles that could be 
used for the positive identification of some body fluids commonly encountered in 
criminal investigations.   
The first aim consists to a systematic review of all information available till 
date about the use of miRNAs as a possible biomarker for body-fluids 
identification. We also acknowledge possible variables that could undermine its 
potential as a confirmatory test.  
The second aim was to determine the relative expression of miRNAs in 2 
forensically important body fluid – blood and urine - and extent the study to 
acknowledge the importance of the quality of the sample and its reflection in 
miRNA profiling.  
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3 - Material and methods 
 
Chapter 1 – Systematic Review:  
 
“Forensic miRNA: Potential biomarker for body fluids?” 
 
In forensic investigation, body fluids represent an important support to 
professionals when detected, collected and correctly identified. Through many 
years, various approaches were used, namely serology-based methodologies 
however, their lack of sensitivity and specificity became difficult to set aside. In 
order to sidetrack the problem, miRNA profiling surged with a real potential to be 
used to identify evidences like urine, blood, menstrual blood, saliva, semen and 
vaginal secretions. MiRNAs are small RNA structures with 20-25nt in length that 
make them less prone to degradation processes when compared to mRNA which 
is extremely important once, in a crime scene, biological evidences might be 
exposed to several unfavorable environmental factors. Recently, published 
studies were able to identify some specific miRNA, however their results were not 
always reproducible by others which can possibly be the reflection of different 
workflow strategies for their profiling studies. Given the current blast of interest 
in miRNAs, it is important to acknowledge potential limitations of miRNA 
profiling, yet, the lack of such studies are evident. This review pretends to gather 
all the information to date and assessed a multitude of factors that have a 
potential aptitude to discrediting miRNA profiling, such as: methodological 
approaches, environmental factors, physiological conditions, gender, pathologies 
and samples storage. It can be asserted that much has yet to be made, but we 
pretend to highlight a potential answer for the ultimate question: Can miRNA 
profiling be used as the forensic biomarker for body fluids identification?  
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Chapter 2 – miRNA profiling:  
 
“Circulating miRNA signatures for blood and urine identification”. 
 
In this report, we choose to test the presence and expression levels of four 
miRNAs in both blood and urine samples obtained from 50 healthy individuals 
from Portugal and study their behavior within those body fluids. 
We conducted a miRNA expression profiling study of 50 healthy adult individuals 
(34% males and 66% females). Our group of study was composed by Caucasian 
individuals with a mean age of 42, 7 years old, with no major pathological 
condition.  Peripheral venous blood and urine were collected from each subjects 
following the obtainment of a written informed consent from all subjects. After 
samples collection, the samples were processed, miRNA extracted and a cDNA 
library was created.  
Afterwards, we proceed to get a relative quantification of our four miRNAs 
selected - miR-127, miR-221, miR-222 and RNU48 - through real-time PCR.  
Statistical analysis was carried out by the computer software IBM®SPSS®Statistics 
(Version 22.0). In order to assess any statistical alterations in our normalized 
miRNAs expression essay we used 2
−ΔΔCt
 method and Student's t test. 
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4 - Chapter 1 
 
 
Abstract 
In forensic investigation, body fluids represent an important support to 
professionals when detected, collected and correctly identified. Through many 
years, various approaches were used, namely serology-based methodologies 
however, their lack of sensitivity and specificity became difficult to set aside. In 
order to sidetrack the problem, miRNA profiling surged with a real potential to be 
used to identify evidences like urine, blood, menstrual blood, saliva, semen and 
vaginal secretions. MiRNAs are small RNA structures with 20-25nt whose 
proprieties makes them less prone to degradation processes when compared to 
mRNA which is extremely important once, in a crime scene, biological evidences 
might be exposed to several unfavorable environmental factors. Recently, 
published studies were able to identify some specific miRNAs, however their 
results were not always reproducible by others which can possibly be the 
reflection of different workflow strategies for their profiling studies. Given the 
current blast of interest in miRNAs, it is important to acknowledge potential 
limitations of miRNA profiling, yet, the lack of such studies are evident. This 
review pretends to gather all the information to date and assessed a multitude of 
factors that have a potential aptitude to discrediting miRNA profiling, such as: 
methodological approaches, environmental factors, physiological conditions, 
gender, pathologies and samples storage. It can be asserted that much has yet to 
be made, but we pretend to highlight a potential answer for the ultimate 
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question: Can miRNA profiling be used as the forensic biomarker for body fluids 
identification?  
 
Keywords: Forensic science, Forensic serology, body fluids, miRNA profiling, 
biological biomarkers.  
 
1- Introduction 
MiRNAs are small non-coding RNAs with approximately 22 nucleotides of 
length that seems to regulate a major part of human genes when combined with 
the RNA-induced silencing complex [1-4]. When this happens, miRNAs controls 
gene regulation by degradation of the mRNA through cleavage or by preventing 
protein synthesis [5]. Well conserved in eukaryotic organisms, they are involved in 
several cellular processes such as apoptosis, development, differentiation and 
proliferation [6-10]. In recent years, numerous studies showed that miRNAs 
profiling had a significant role as disease biomarkers, as a powerful tool to 
understand gene regulation mechanisms such as development mechanisms and 
gene regulatory networks; and also, due to its tissue specific pattern, in forensic 
sciences allowing the identification of body fluids [11, 12]. 
Ambros and co-workers identified the first miRNA, miR-lin-4, in 1993 [13] . 
They observed that this miRNA was responsible for the timing of development 
events of C. elegans larvar stages, they also discovered  that lin-4 was not able to 
code a protein, but instead encodes what they called small RNAs [13]. Later, a 
second miRNA, let-7, was described by Pasquinelli et al. and was confirmed its 
presence in human tissue among different species. This observation 
demonstrated that these miRNAs were conserved through lineages, making that 
way, and for the first time, an allusion of an extended phenomenon [14].  
If DNA profiling allows the identification of individuals through their 
respective DNA signatures, it does not identify the type and source of the 
evidence. Based on the theory that each type of body tissue has a distinctive RNA 
signature, mRNA profiling surge as an advantageous procedure to identify 
relevant human body fluids. Despite the achievement of mRNA profiling, the 
mRNA susceptibility to degradation by physical or chemical factors has always 
been problematic [15]. In 2009, miRNA profiling to forensic field was introduced 
by Hanson et al.,  revealing the ability of miRNAs to identify different body fluids 
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through miRNA signatures [16]. For example, when a certain miRNA is specific to 
a human tissue and cannot be found in another sample or when its concentration 
is significantly elevated and low in other samples, those characteristic profiles of 
miRNAs may allow the identification of human body fluids such as blood, 
menstrual blood, semen, saliva and vaginal secretions from others human tissues 
[16-21]. Argonaute proteins are catalytic component of the RISC complex, 
responsible for the biological process called RNA interfering [1, 2, 4]. Their tight 
relationship with miRNA makes them much more stable to degradation processes 
when compared with mRNA culminating in a superior discriminatory potential, 
especially in challenging conditions [22, 23]. 
Through this review we pretended to gather all information available till 
date about the use of miRNA as a possible biomarker for body-fluids 
identification. But also, acknowledge possible variables that could undermine its 
potential as a biomarker.  
 
2- miRNA as potential body fluid biomarkers 
Body fluids constitute a beneficial assistance for forensic pathologists and 
researchers to present means of identifying the perpetrator of a crime and 
describe how an individual died or suffered through an assault. After being 
detected and recovered, biological traces need to be identified but some 
biological stains are difficult to undoubtedly identify, for example, venous blood 
versus menstrual blood. Through the years, many types of approaches such as 
chemical tests, immunological tests, microscopy and spectroscopic methods have 
been used to identify body fluids, however, some of them, like luminol for blood, 
are presumptive [24]. Henceforth, the potential of miRNA as a biomarker is being 
studied by means of a molecular genetics-based approach but can miRNA be 
considered a good biomarker for biological fluids? Idealistically, biomarkers 
should be able to fulfill a quite imperative number of characteristics [25]. It needs 
to be available to analyze through non-invasive methods; have a long half-life in 
samples; be unalterable by physical or chemical factors; it should be specific to a 
tissue; but most of all, it should be a fast, simple, accurate, reproducible and an 
economical method [25]. If Hanson and co-workers were the first team to 
introduce miRNA to body fluids identification in forensic field, soon enough other 
authors directed their work toward miRNA profiling. Figure 1 displays an overview 
of all miRNA that different authors considered as possible body-fluid biomarkers. 
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In this figure it is emphasized the fact that almost all the studies performed had 
different outcomes and only few miRNAs are confirmed by two or more reports. 
Studies performed by Hanson, Zubakov, Wang et al. seem to point that miR-16 
might be venous blood-specific, and consequently, a potential biomarker for 
blood stains [16, 17, 20]. Confirmed by three different studies, miR-205 was 
recognized as a good biomarker for saliva but Wang and colleagues concluded 
otherwise, sustaining that miR-205 may be epithelium specific and not saliva 
specific [20]. As a common act of vandalism, the urinating act can be a source of 
trace DNA but also particularly good for drug screening, especially drugs of abuse 
[26, 27]. Therefore, it is interesting to underline that no miRNA was detected as 
potential biomarker for urine, which is an important human fluid in forensics [18]. 
The lack of homogeneity and the non-reproducibility of results from different 
groups can be the outcome of dissimilar approaches to reach the one and same 
goal, highlighting the necessity of standardization for miRNA biomarker 
assessment. 
Figure 1 - overview of all miRNA considered as possible body fluids biomarkers by [a] Hanson et al. [16]; [b] 
Zubakov et al. [17]; [c] Weber et al.[18]; [d] Courts et al. [19]; [e] Wang et al.[20]; and [f] Omelia et al.[21] 
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  2.1 – Samples management and storing  
The selection of adequate sample, sample processing and RNA extraction 
are crucial steps for miRNA profiling. The inclusion of degraded RNA in an 
experiment may result in the inability to detect and quantify specifics miRNA and 
enable the possibility to get reliable results [28]. However, it is now possible to 
extract high-quality miRNA from fresh tissues, cell lines, plasma, and serum 
among other body fluids to guarantee the quality and quantity of the sample, 
being both of them parameters that have significant impact on the result [18, 29].  
Collecting samples is a very important stage to the entire profiling process. 
When collecting a sample, it might get contaminated with others than the 
pretended evidence – as ground soil, microorganisms, etc. It is common sense to 
believe that inadequate handling of the evidence can prevent or confuse the 
interpretation of the results. Another issue that needs to be raised is the effect of 
time exposure of the evidence to external factors until its collection and posterior 
extraction; we also have to consider the post-mortem interval. To our knowledge, 
there are no published studies that considered their potential effect on miRNAs 
profiling, nonetheless, we thought important to highlight those interrogations. 
Nowadays, dried serum spots are commonly used for body fluid storage, 
namely blood. Can miRNAs be recovered in good conditions from dried samples? 
Patnaik et al. published an essay considering miRNA preservation in dried serum 
blots and they concluded that miRNA preservation was indeed reliable for a 
posterior profiling. However, they noticed that incomplete drying of blots before 
storing was prejudicial for its preservation [30]. 
Acknowledging that criminal investigation can take several years to 
resolve, can prior extracted miRNA remain in good conditions after mid-term / 
long-term storage?  A very few studies worked to highlight this question with 
forensic relevant body fluids, though some work was made for human serum 
[31]. According to the study, four miRNAs were considered to evaluate the effect 
of storage in human serum at –80ºC (with and without thaw), –20ºC (with and 
without thaw) and at room temperature. Interestingly, mir-451 was one of the 
four miRNA considered and, as showed in figure1, it is also one regarded in 
venous blood. The authors concluded that no significant difference in miRNA 
levels was verified between –80ºC and –20ºC in short-term storage (10 days). 
However, when stored at roomed temperature, miRNA levels were drastically 
decreased, yet still detectable. Moreover, repeated freeze and thaw cycle also 
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significantly decrease miRNA levels compared with continuous storing, thought 
that result seems to be inconsistent with other authors research work results [32-
34]. For mid-term storage (<20 month) no major differences on miRNA levels 
were observed between –80ºC and –20ºC, nonetheless some individual miRNA 
were seriously affected by those conditions. Finally, they explored the effect 
caused by long-term storage at –20ºC and observed a slightly decrease within the 
range of 2–4 years; after 6 years of storage a significant decrease of miRNA levels 
was perceived that only accentuates in the course of time [31]. In summary, 
miRNA seems to be almost unaffected by freezing temperatures (–20ºC) for at 
least 2–4 years in human serum, however it is indeed required a similar research 
work for others human body fluids as they may not respond the same way to 
such low temperature storage.   
 
 2.2 – MiRNA profiling – methodologies 
MiRNAs proprieties bring a challenging game to its profiling, with more or 
less than 22 nucleotides in length (the size of a traditional primer) the traditional 
primer binding is impossible. In order to sidetrack the problem, the elaboration 
of a smaller primer is required, demanding a lower melting temperature and 
ultimately affecting the efficiency of the PCR. Furthermore, the short length and 
discrepancy in GC contents leads to a wide variance of melting temperatures 
resulting in another challenge to its reliable profiling. 
Nowadays, a large cluster of methodologies has the capacity to be used for 
miRNA profiling. Methodologies like Northern Blotting using locked nucleic acid, 
RNase protection essays and in situ hybridization methodologies are known for 
miRNAs detection [35-37] . However, we decided to highlight the three major 
methods that are being currently used: microarray (hybridization-based method), 
qRT-PCR (quantitative reverse transcription PCR) and RNA sequencing. 
Interestingly, the groups taken in considerations for their work in miRNA profiling 
for body fluids identification used different combinations of methods. Could 
those combinations be responsible for the heterogeneity of results showed in 
figure 1? This hypothesis was suggested by Zubakov et al. when they tried to 
replicate the results obtained by Hanson and colleagues – for vaginal secretions, 
menstrual blood and saliva – and failed [17].  
The concept of DNA microarray technology resides on the ability of a 
single strand of DNA (probe) to bind to a complementary strand of DNA 
(identified as target). The targets miRNA are initially reversed into cDNA and 
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fluorescently labeled.  Once the targets successfully hybridized with the probes 
(known sequences) the microarrays are scanned to detect the fluorescence of the 
DNA probes, which can be measured using a fluorescent scanner [38]. Microarray 
technology has, as its main advantages, the ability to study the expression of 
thousands of genes or their RNA products at once involving a fairly low cost 
price. However, despite its high-throughput, the lack of specificity and sensitivity 
compared to other methods such as qRT-PCR or RNA sequencing is considered as 
a real disadvantage that can tamper the results. Another limitation resides on the 
large amount of sample required to do the experiment, which is a major problem 
with forensic samples. Moreover, microarray only provides results about the 
genes that are included in the array itself preventing the identification of novel 
miRNAs and unlike qRT-PCR it cannot be used for absolute quantification. 
RNA sequencing (RNA-seq) is established as a high-throughput sequencing 
method and one of the major approaches to miRNA expression profiling. RNA-seq 
technology begins with a reverse transcription of the miRNA to a cDNA library 
[39]. Once the library is created, adaptors are applied to one or both limits of the 
sequences enabling a massive sequencing of the cDNA library [40]. As a high-
throughput next-generation sequencing platform, RNA-seq is the only method 
able to identify both known and most importantly, novel miRNAs but also, 
differentiates miRNAs that are very similar, namely, distinguish miRNA that 
diverge by only one nucleotide resulting as a real advantage when compared to 
microarray and qRT-PCR technologies. Just like microarrays, RNA-seq cannot be 
used for absolute quantification but also presents as a major disadvantage the 
necessity of an important support of bioinformatics tools which presents relevant 
challenges through the process. Moreover, the cost associated with RNA-seq per 
sample is still high although it has been decreasing over these last years.  
Quantitative reverse transcription PCR (qRT-PCR) relies on reverse 
transcription of miRNA to cDNA, followed by qPCR and posterior real-time 
monitoring of the resulting products [41]. qRT-PCR is a very sensitive and specific 
(especially with TaqMan®–based detection) compared to the other two precedent 
approaches and can be used for absolute quantification. In forensic cases, 
quantity of genetic material collected can be little and therefore, it is important to 
use a methodology that requires a fairly low amount of RNA. qRT-PCR beyond 
being a well-established method, it also requires a low amount of RNA and has a 
fairly low cost per sample. On the other hand, it also present a significant 
disadvantage, it cannot identify novel miRNAs.  
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Hanson, Zubakov and respective co-workers used qRT-PCR for their 
experiment. However, Zubakov et al. failed to replicate some of the results 
reported by Hanson and co-workers [17]. Even using the same platform, two 
different methodologies were performed: SYBR
®
 Green and TaqMan
®
. SYBR
®
 Green 
detects PCR products by binding, nonspecifically, to double-stranded DNA, which 
can generate false positive results [42]. On the other hand, a TaqMan
®
 approach 
relies on a specific hybridization between probe and target, required to generate 
fluorescent signal [42]. The incorporation of target and probe leads to an increase 
of the sensitivity and specificity of the qRT-PCR platform. Those different 
methodologies are considered by Zubakov et al. as one possible reason for the 
discrepancy of results. Moreover, when compared the workflow of the authors 
considered for this review, not only the methodologies used were different but 
also their choice of the normalization gene. Used to remove disparities across 
samples, and despite its crucial importance to obtain accurate results, there are 
no consensus normalizations for either of the methods reviewed [43]. This 
reinforces the necessity to define a concrete workflow for miRNA profiling and 
standardize each method (fig. 2).  
2.3 - Gender and miRNAs 
In order to elucidate if miRNAs can or not be considered as biomarkers for 
body fluid identifications, we gather the information  in published reports that 
involves miRNAs presented by authors as biomarkers for human body fluids, and 
show their  different expression levels when influenced by both biotic and abiotic 
factors. In this section, miRNAs profiles that differ with gender will be the main 
focus. 
The research work done by Duttagupta et al. highlighted miRNAs that 
showed to be gender specific in normal male and female population. A microarray 
analysis performed in human plasma, emphasize a subset of four miRNAs (miR-
548-3p, miR-1323, miR-940 and miR-1292) that were found to be up regulated in 
females (63–95%), demonstrating its potential to distinguish gender. 
Interestingly, none of these miRNAs were significantly down-regulated [44]. Those 
results would be expected if the concerned miRNAs were sex tissue specific, 
namely mir-940. As cervix specific, it is logical that mir-940 is found up-regulated 
in women plasma when compared to male samples. However, the other three 
miRNAs were not female sex tissue related, yet, they also were up-regulated.  In 
2012, Wang et al. showed that mir-130b and mir-18b had slightly higher 
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concentrations in male serum samples compared to females [45]. Though, we 
should note that the authors were not able to exclude the possibility that both 
miRNAs may be associated with gender-association functions [45]. Furthermore, 
another research was drawn up in 2013 and studied the association of circulating 
serum miRNAs with the metabolic syndrome (MetS) and related it to gender. They 
attested a significant change in the miRNA profile, notably for two miRNAs, let-7g 
and miR-221, which were overexpressed in the serum of individuals with MetS (P 
= 0.004 and P=0.010, respectively) and more prominent in women [46].  
Idealistic biomarkers should not be expected to change by any means, 
however any discrepancy to that rule may underline its role as a biomarker. In a 
forensic point of view, it would be reasonable to question whether those gender-
related differences in miRNA levels may occur in others biological fluids because, 
if non gender-tissue specific profiles of miRNAs changes, those miRNAs may not 
be suitable as biomarkers (table 1).  
 
2.4 - Pregnancy and miRNAs 
Recent reports have shown that a large number of miRNAs are expressed 
in human placenta. These miRNAs, produced by human trophoblast cells, can be 
secreted into maternal serum or plasma through an exosome-mediated pathway 
[47-50]. There is why we can question ourselves whether or not pregnancy affects 
miRNAs profiling. In this section, we show that pregnancy indeed leads to 
different expression level of some miRNAs, especially in those pointed out as 
possible biomarkers for body fluids.  
Chim et al. searched for placental miRNAs in maternal plasma and 
detected four miRNAs (miR-141, miR-149, miR-299-5p, and miR-135b) at higher 
concentrations in the maternal plasma before delivery when compared to after 
delivery and concluded that these miRNAs were placental-specific. The plasma 
concentration of miR-141 increased with gestational age showing the highest 
concentration in the third trimester [48]. Defined by different authors as saliva-
specific, miR-141 was reported by Chim et al. as placental-specific in maternal 
plasma [48]. Therefore, further studies are needed to confirm these results. 
Interestingly, miR-299-5p, showed as plasma specific works also as placental-
specific when up-regulated.  
By studying a panel of 723 human miRNAs, Miura et al. found that 24 
miRNAs showed significantly decreased concentrations in maternal plasma after 
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the termination of delivery. 13 of the 24 genes encoding pregnancy-associated 
miRNAs were expressed only in placenta and the remaining 11 miRNAs were 
produced predominantly in placenta tissue [49]. These miRNAs were considered 
pregnancy associated and almost all are located in chromosome 19, known to 
contain a large cluster (C19MC) of miRNAs genes and other genomic elements 
involved in placental growth and development [51, 52]. Other placental miRNAs 
(miR-516-5p, miR-517*, miR-518b, miR-520a*, miR-520h, miR-525 and miR-526a) 
were detected in maternal plasma by Kotlabova et al. and recognized as 
pregnancy associated miRNAs [53]. Gilad et al. compared serum miRNAs levels in 
pregnant and non-pregnant women and observed that three of them were highly 
expressed during pregnancy (miR-526a, miR-527 and miR-520d-5p) [50, 51].  
Many miRNAs have also been detected in trophoblast cells, a 
heterogeneous group of fetal cells formed during the first stage of pregnancy 
[54, 55]. Morales-Prieto et al. analyzed these cells in different stages of pregnancy 
(first and third trimester) and showed that the level of C19MC miRNAs increases 
significantly from first to third trimester, while C14MC miRNAs levels have the 
opposite pattern. Also, miR-371-3 cluster had a small increase with advance of 
gestational age. These clusters have several miRNAs that are considered 
placental-specific [56]. Nevertheless, more studies are needed to compare these 
results with non-pregnant women and with other body fluids. 
 
2.5 - Age-related miRNAs  
MiRNAs have recently emerged as important regulators of aging and, since 
then, the number of studies has increased. The first genetically identified miRNAs 
were Caenorhabditis elegans lin-4 and let-7. These and others miRNAs have been 
well-studied in this model and seems to show that it regulates lifespan and 
predicts individual longevity [57-60].  Boehm and Slack found that the 
overexpression of miRNA lin-4 results in an extended lifespan of C. elegans, 
whereas the loss of lin-4 function has an opposite effect [61]. Ibáñez-Ventoso et 
al. suggested that, since many age-related miRNAs are conserved, their human 
homologs might be similarly regulated to modulate age-related decline and age-
related pathology [57].  
By definition, idealistic biomarkers should not be altered by any means. It 
is why it is indispensable to study miRNA profiles when targeted by both internal 
and external factors in important forensic body fluids. Only the ones stable 
enough have the potential to be considered biomarkers.  Several studies in mice, 
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primates and humans compare expression levels of miRNAs in younger and older 
tissues but there are only a few works about the age-related changes in miRNAs 
levels in biological fluids.  
Li et al. studied the expression of miRNAs in rat liver during aging and 
observed that miR-34a and miR-93 increase in the middle and old-age rat liver, 
compared to young rats [62]. Maes et al. also investigated the expression of 
miRNAs in the same tissue and proved that a gradual increase of miR-669c and 
miR-709 was observed from the mid-age (18-33 months), whereas miR-93 and 
miR-214 are increased in extremely old (33 months) mice [63]. The up-regulation 
of these miRNAs caused a repression of oxidative defense genes by targeting 
transcription factors important for detoxification and regeneration of the liver, 
which decreased with age [58, 62, 63]. Other research work done by Li et al. 
examined the role of miRNA regulation in mouse brain during the normal aging 
process and their results suggested that, like in the liver, the expression of miR-
22, miR-101a, miR-720 and miR-721 increased with aging, starting from mid-
adulthood, with this up-regulation being observed since 18 months of age [64]. 
The majority of the up-regulated miRNAs were predicted to target and correlate in 
expression with components of the mitochondrial complexes [58, 59, 64]. Other 
studies were done in mice tissues, like skeletal muscle, by Hamrick, Drummond 
and respective co-workers [65, 66].  
Somel et al. found that few gene expression changes are unique to aging. 
They measured miRNA expression in the prefrontal cortex of humans and rhesus 
macaques and detected that, in human, 31% of 373 miRNAs showed significant 
expression changes with age. These results had good positive correlation 
between humans and macaques (P < 0,020) [67]. Recently, it has been established 
the first miRNA and noncoding RNA expression atlas of the developing human 
brain with differential expression signatures between fetal, early postnatal and 
adult brain tissue samples [68]. Various miRNAs have also been shown to be 
down-regulated in peripheral blood mononuclear cells from old American 
individuals (miR-103, miR-107, miR-128, miR-130a, miR-155, miR-24, miR-221, 
miR-496, miR-1538) compared to younger individuals [59]. The loss of miRNA 
function during the aging process may be due to transcriptional repression, 
deletion, mutation, epigenetic silencing or aberrant miRNA processing and 
suggest that miRNAs and their predicted targets have the potential to be 
diagnostic indicators of age [59]. ElSharawy et al. identified 80 age-related 
miRNAs in blood samples with 16 miRNAs being up-regulated and 64 (80%) down-
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regulated compared to younger individuals. Their results showed that some 
miRNAs identified previously by Hooten et al. also appeared in this study, such as 
miR-103, miR-107, miR-24 and miR-130a [69]. Hackl et al. also identified four 
down-regulated miRNAs that are involved in aging and, three of them, were 
confirmed by ElSharawy et al. (miR-17, miR-20a and miR-106a) [69, 70]. It is 
interesting to note that some of these miRNAs are also considered by some 
authors as body fluids biomarkers (Fig. 1). For example, miR-17 was recognized 
as a good biomarker for semen and a probable age-related miRNA; miR-130a 
seems to be colostrum-specific and an aging biomarker; miR-20a and miR-106a, 
which were found in blood samples, were recognized as venous blood-specific 
miRNAs but also age-related miRNAs. Recently, other research work was done in 
body fluids. Hooten et al. provided evidence that, in human serum, miRNAs were 
differentially expressed with aging. In this study, they found a significant 
decrease in expression of miR-151a-5p, miR-181a-5p, and miR-1248 and it 
happened regardless of gender and race, suggesting that they may be good age-
related biomarkers. All three miRNAs were predicted to be central mediators of 
inflammatory pathways and important for organismal development and survival, 
suggesting that a decreased expression may result in the development of age-
related phenotypes and diseases [60]. However, it would be necessary further 
studies to corroborate all these results obtained so far. 
 
2.6 - Environmental factors  
In order to be considered as a confirmatory test in forensic serology, it is 
important to acknowledge abiotic factors that could alter miRNAs expression 
levels in human body fluids. The interaction between miRNAs and environmental 
factor is undeniable. More importantly, miRNAs signatures seem to be induced by 
some factors as temperature, drought, pH, among others.  In this chapter, we 
scrutinized the still slightly studied topic. 
 
2.6.1 – Temperature 
Recently, miRNAs have been linked to environmental stress factors, 
however, the relationship between miRNA expression and stress responses is just 
beginning to be explored.  
MiRNA expression is modulated by temperature, dehydration, radiation 
and other factors. In plants, 19% of miRNAs are involved in the response to 
4 – Chapter 1 
 65 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
temperature stress [71]. Sunkar and Zhu demonstrated that miR-393, miR-397b, 
miR-402 and miR-319c, in Arabidopsis thaliana, were up-regulated by cold (low 
temperature) whereas miR-389a was down-regulated [72]. The study done by Lee 
et al. identified miR-156, miR-163, miR-169, miR-172, miR-398 and miR-399 as 
temperature-responsive miRNAs of Arabidopsis [71]. MiR-393 was also strongly 
up-regulated by cold in the research work done by Liu et al. but also reported by 
others in other plants [73, 74]. In orchid Phalaenopsis, four low temperature-
responsive miRNA families were identified – miR156, miR162, miR528 and 
miR535 [75]. Though, the expression of miRNAs not only changes with 
decreasing temperatures. May and colleagues observed that some miRNAs 
changes their expressions by increasing temperature 3-6ºC and, among all 
predicted miRNAs, four were increased significantly [76]. 
Some studies have shown that, due to extreme environmental conditions, 
the expression of miRNAs is changed in both invertebrates and vertebrates 
animals. For example, it was evaluated the freeze tolerance in frogs and 
gastropods and the hibernation in ground squirrels [77-79].  
Till date, there are a very few studies toward human body fluids and 
environmental factors impact on them.  There is why we decide to look toward 
miRNA behavior in plants, invertebrates and vertebrates when conditioned by 
adverse conditions. However it is important to acknowledge that in plants, 
miRNAs have some differences functions compared to animals.  
In humans, Benson and colleagues studied the variability of miRNA in 
whole blood, stored until 12 hours at room temperature. They concluded that 
MiR-16 and miR-223 were not altered by room temperature and established that 
these miRNAs were stable in whole blood and could be used as plasma-specific 
miRNAs [80]. However, more studies are needed in order to understand whether 
human miRNAs are altered by temperature in body fluids. 
 2.6.2 – Radiation 
The expression of specific plant or animal miRNAs has been shown to be 
altered under abiotic stresses such as radiation. Many studies have been done to 
prove that these miRNAs play important roles in response to radiation, as UVB 
stress in plants. The results obtained suggested that each plant has its own 
special UVB-regulated network [81, 82]. 
It was explored the expression of miRNAs in mouse peripheral blood and 
the study concluded that miRNA expression signatures were radiation type-
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specific and dose and time-dependent [83]. Furthermore, Dressman et al. showed 
that radiation-induced gene expression signatures derived from mouse blood can 
predict the irradiation status of human samples with very good accuracy [84]. 
In humans, several studies were performed. Kraemer et al. showed that UV 
irradiation of human primary keratinocytes modulates the expression of several 
cellular miRNAs, comparing the effect of UVA and UVB irradiation on miRNA 
expression. In UVA-irradiated cells, 27 miRNAs were differentially expressed 
compared to non-irradiated cells, whereas in UVB-irradiated cells 28 deregulated 
miRNAs were identified. These results demonstrate that miRNAs are differentially 
expressed in response to UVA and UVB and can play an active role in the 
diagnosis of some cancer diseases [85]. Other study, done by Templin and 
colleagues, investigated the potential of radiation-induced miRNA expression 
profiles in peripheral blood cells to provide biomarkers for radiation exposure 
that could be used in therapeutic or diagnostic settings. The results were 
obtained immediately before and after four hours of total body irradiation with 
1.25 Gy x-rays and they concluded that 45 miRNAs were statistically significantly 
up-regulated after irradiation. This study suggested that miRNA expression 
signatures can be used as biomarkers of radiation exposure [86].  
Some studies on the influence of radiation exposure in miRNAs were 
performed in body fluids. Cui and co-workers showed that plasma miRNA 
expression signatures distinguished mice that received total body irradiation 
doses of 0.5 Gy, 2 Gy, and 10 Gy with accuracy, sensitivity and specificity above 
90%. According to these, they concluded that plasma miRNA profile can be 
predictive of different levels of radiation exposure [87]. The evolution of miRNA 
expression subjected to different ranges of radiation may also be indicative for 
various physiological responses and pathological stages. Jacob and associates 
compared 600 miRNAs in serum and they observed that miR-150, abundant in 
lymphocytes, exhibited a dose and time dependent decrease with increase of 
radiation range and was suggested as a marker indicative of lymphocyte 
depletion and bone marrow damage [88]. Interestingly, miR-150 was considered 
as body fluid-specific (venous blood) but also a good biomarker for radiation.  
 
 2.1.2 – Other environmental factors  
There are other factors that are still slightly studied, but which need to be 
mentioned as promoters of the differential expression of miRNAs, such as 
drought or dehydration, pH and salinity. 
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One of the first studies in this field was done by Sunkar and colleagues. In 
this study, a pair of samples from Arabidopsis (untreated and treated) was 
assayed for each treatment and total five microRNAs were observed to be 
regulated by one or more of environmental factors [72]. Liu et al. also studied, in 
Arabidopsis, the expression of miRNAs to environmental stress factors and 
concluded that 14 of them were differentially regulated by one or more stress 
conditions. MiR-168, miR-171 and miR-396 responded to high-salinity, drought 
and low temperature [73]. The research work done by Zhao et al. compared their 
results with the study from Liu and observed that three miRNAs (miR-319c, miR-
393 and miR-397b) had conserved homologs in rice [89]. MiR-393 and miR-397b 
were up-regulated by dehydration in both studies. Furthermore, the up-regulation 
of miR-169g due to dehydration suggested that this miRNA might play an 
important role in drought stress in rice [73, 89]. Other three studies also 
observed that miR-393 was up-regulated during drought stress in various plant 
species [90-92] . As mentioned above, many studies have already been made on 
plants but studies in animals are lacking. Recently, Wu et al. analyzed the effects 
of whole body dehydration on miRNA expression in three tissues (liver, kidney 
and skin) of African clawed frog, Xenopus laevis. This study showed a tissue 
specific mode of miRNA expression during dehydration [93]. 
There are no developed searches in body fluids subject to dehydration or 
drought but, from these studies, it is possible to expect that what happens in 
plants and animal tissues may happen also in body fluids. 
 
2.7 – Pathologies and specific body-fluid miRNAs 
A considerable amount of the research work done toward miRNAs is 
directed to pathological cases. By all means, its “expression variation” seems to 
pinpoint biological deregulations that trigger several events as invasion, 
metastasis, proliferation and differentiation in cancer, but also responsible for 
neurodegenerative disorders [94-99], inflammation processes [23, 30, 35, 36, 39, 
100, 101] and infectious diseases [102-105]. Also recognized as oncomirs, 
miRNAs can act as oncogenes when they are found in higher expression levels, 
culminating by promoting tumor development; but also as tumor suppressor, 
when their expression is reduced in cancer cells, preventing tumor development 
[106, 107].   
Once again, if we assume the possibility of miRNAs as biomarkers for body 
fluid identification, they should be stable regardless different internal conditions 
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however, upon pathological conditions, miRNAs different expression levels seems 
to have a key-role importance.  
The samples used for the research seems to be confined to tumors cells 
and plasma/serum, but only few numbers used the ones we approaches for this 
review. Here, we will reveal some miRNAs with altered levels of expression in 
cancer. Acute Myeloid Leukemia is a cancer of the myeloid lineage of leukocytes 
that interferes with the production of normal blood cells and after reviewing the 
literature, it was found a decreased of miR-150 in human plasma [108]. It is also 
important to observe that miR-150 was determined by Court and Medea as a 
venous blood specific miRNA [19]. For bladder cancer, some studies were done in 
urine samples and reported an up-regulation of miR-96, miR-126 and miR-182 
[109, 110]. Weber et al. considered the  high concentration in plasma of miR-182 
as a biomarker for plasma identification when compared to other body fluid 
samples [18]. However, if in bladder cancer, miR-182 is up-regulated in urine, can 
this miRNA be a good biomarker for plasma? Can we really distinguish both 
samples when miR-182 is up-regulated in patients with bladder cancer? Clearly, 
more studies are needed to be done toward those problems in order to clarify 
which miRNAs can be really considered as “specific” that is, idealistically not 
altered by any means. For breast cancer, some miRNAs were decreased in both 
plasma and serum samples [111-115] but other interesting miRNAs were found 
increased such as miR-10b, miR-141, miR-200c, miR-203, miR-373, miR-451 and 
miR-801 among others in plasma [112, 113, 116, 117]. In serum, the literature 
pinpoint a large amount of miRNAs as up-regulated but it is to mention that miR-
10b is founded to be also up-regulated just as miR-299-5p [114, 115, 118-120]. 
In patients with colorectal cancer, miR-141 was found up-regulated in plasma 
[121]. In esophageal squamous cell carcinoma, it was showed an increase of miR-
10a and miR-223 in serum samples [122]. MiR-106b was found to be up-
regulated in plasma while miR-20a was up-regulated in both serum and plasma in 
patients with gastric cancer [123-125]. Lung cancer is one of the diseases with 
more associated miRNAs biomarkers in literature to date. In plasma, miR-16, miR-
106a and miR-126 were found decreased while miR-182 and miR-451 were found 
increased [126-129]. Moreover, in serum, miR-16, miR-106a, miR-141, miR-200c 
and miR-593* were down-regulated whereas miR-10b, miR-182, miR-205 and miR-
223 were up-regulated [11, 107, 127, 130, 131]. For prostate cancer, it was 
showed an up-regulation of miR-26a and miR-141 in serum [32, 132, 133]. 
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The unique profile of miRNAs in cancer and their expressional variation in 
different types of tumors reveals an additional layer of complexity for body fluid 
identification through miRNAs. As it was said for the others variables, more 
studies need to be planned to answer whether miRNA can or not be used as a 
reliable biomarker for body fluid identification.  
 
Table 1 – Overall of some of the human miRNAs considered for this review.  
Variable Deregulation 
Tissue / 
Body Fluid 
miRNAs References 
Gender            
Female Increase 
Plasma miR-940 miR-548-3p miR-1292 miR-1323 [44] 
Serum let-7g miR-221   [46] 
Male Increase Serum miR-18b miR-130b   [45] 
Pregnancy 
Increase 
Plasma 
miR-135b miR-141 miR-149 
miR299-
5p 
[48, 53] 
 
miR-516-5p miR-517* miR-518b 
miR-
520a* 
 
miR-520h miR-525 miR-526a  
 
Serum miR-526a miR-527 miR-520d-5p 
 
[50] 
Age 
Decrease 
 
Blood 
miR-17 miR-20a miR-24 miR-103 
[59, 69, 70]  miR-107 miR106a miR-128 miR-130a 
 
miR-155 miR-221 miR-496 miR-1538 
 Serum 
miR-151a-
5p 
miR-181a-
5p 
miR-1248  [60] 
Radiation Decrease Serum miR-150 
   
[88] 
Pathology 
  
   
  
Acute M. 
Leukemia 
Decrease Plasma miR-150 
   
[108] 
Bladder Cancer Increase Urine miR-96 miR-126 miR-182 
 
[109, 110] 
Breast Cancer Increase 
Plasma 
miR-10b miR-141 miR-200c miR-203 [112, 113, 
116, 117] miR-373 miR-451 miR-801  
Serum miR-10b miR-299-5p  
 
[118-120] 
Colorectal Cancer Increase Plasma miR-141    [121] 
Esophageal 
Cancer 
Increase Serum miR-10a miR-223 
  
[122] 
Gastric Cancer Increase 
Plasma miR-20a miR-106b 
  
[123, 124] 
Serum miR-20a  
  
[125] 
Lung Cancer 
Decrease 
Plasma miR-16 miR-106a miR-126  
[33, 127, 
128] 
Serum 
miR-16 miR-106a mi-141 miR-200c [107, 130, 
134] miR-593*    
Increase 
Plasma miR-182 miR-451   
[33, 128, 
129] 
Serum miR-10b miR-182 miR-205 miR-223 
[11, 131, 
135, 136] 
Prostate Cancer Increase Serum miR-26a miR-141 
  
[32, 133] 
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3 - Conclusion and future considerations 
 
 
 
Studies involving miRNAs are still in its early stages and that is why every 
factor with potential relevance needs to be studied. The main problem associated 
with miRNA as to do with the rush to go straight to the main goal without 
studying those variables. When the scientific community started to talk about 
miRNA profiling in a forensic purpose, numerous studies surged with what they 
considered miRNA body fluids-specific. However, when reviewed all the results, it 
is easy to question whether or not physiological conditions, genetic, clinical, 
technical and pre-analytical variables have the power to induce other outcomes. 
Within these review, we tried to elucidate some of those variables assessing 
parallel studies that mentioned some of their effects. However, mostly of them 
were not aimed toward biological fluids (at least not on the forensically important 
Figure 2 – miRNA profiling workflow for body fluid identification and potentially relevant variables that need to 
be study. 
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ones) and, as in all biological sciences, the parallelism between results leads to 
obvious mistakes. That is why, before trying to obtain a profile it is indeed 
needed to stop and focus on every possible situation to enhance the chances to 
achieve in reliable and reproducible results.  
Here, we started to question problems related with storing conditions and 
we concluded that they were indeed affected, yet, those result were obtained 
from serum. In this situation it is reasonable to question how blood, semen, 
saliva, urine and vaginal secretions samples would be affected by short/long-term 
storage. We also reviewed the three major methods used to date: microarray, 
qRT-PCR and RNA sequencing, all of them with their advantages e disadvantages. 
At this point, there is no convention between laboratories for miRNA profiling 
despite the fact that it is consensual that different platforms lead to different 
results. The reflection of that problem can easily be spotted, for example, when 
some authors tried to reproduce some of other group results and failed, 
enhancing the necessity to define a concrete workflow for miRNA profiling 
assessment. Can gender or physiological conditions such as age or pregnancy 
alter microRNA profiles in body fluids samples? Apparently yes, however it would 
be necessary to expand the research to other body fluids. Are those alterations 
also ascertained in other body fluids other than serum and plasma? There is no 
evidence to date, however it would be very important to acknowledge this 
possibility. In theory, if I assume that a certain miRNA is in a higher concentration 
in venous blood and low in menstrual blood, that concentration variation would 
allow the distinction of those two samples. However, if for some reason miRNA 
levels were altered, this theory would lose its purpose and undermine miRNAs 
potential as a biomarker. Today, a large amount of the research with miRNAs 
regards pathological conditions namely cancer. MiRNAs expression variation 
reflects biological deregulations and it can be observed within a various amount 
of human tissue. Unlike the precedent factors, there are more studies that include 
forensically relevant body fluids such as blood and saliva. However, it would be 
required to verify those variations in other body fluids.  
These data pretended to give an overall look, in a forensic point of view, of 
miRNA profiling and a multitude of factors that have the potential of altering it. 
Despite the unquestionable potential of miRNA profiling, the research work done 
to date has raised a number of interrogations and it would be wise to start 
researching their answer. Our resumed conclusions would be recapitulated in 
response to two questions: Are miRNAs the forensic biomarkers for body fluids 
4 – Chapter 1 
 72 miRNA as biomarker for body-fluids identification. Its role in Forensic Sciences  
 
identification? No, at least not today. Can miRNAs be the forensic biomarkers for 
body fluids identification? We would say yes, however there is a lot of work to be 
done to reliably answer that question.  
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Abstract 
In forensics, the identification of blood, semen or vaginal secretions can 
represent an important support in a criminal investigation. Those biological 
samples can be used as a source of DNA but also can hold, only by their 
presence, the most probative value.  Throughout many years, many 
methodologies were used to identify them but all presented serious drawbacks. 
Lately, mRNA surged as a potential tool for body fluid identification but their 
sensibility to both biotic and abiotic factors were a serious disadvantage, even 
more pronounced in forensic samples. Since 2009, miRNA profiling surged as a 
possible emergent tool as a confirmatory test in forensics due to their tissue 
specific pattern of expression. Unlike mRNAs they are much more stable due to 
their properties whose makes them less susceptible to degradation processes.  
In this report, we studied the relative expression patterns of miR-127, miR-
221, miR-222 and RNU-48 in 50 individuals samples (urine and blood) in order to 
define whether or not those could be used as biomarkers for urine and blood 
identification.  
In addition to evaluate whether or not our miRNAs could be considered as 
biomarkers, we came across with two others conclusions: the impact of miRNA 
purity in miRNAs relative quantification and the adequate selection of the 
normalization gene for blood and urine identification.  
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1- Introduction 
Human body fluids are important components to rely on a criminal 
investigation [1-4]. As a matter of fact, a complainant’s body fluids present on 
items belonging to a suspect – or vice versa – holds the most probative value [5]. 
For example, in a case of an alleged sexual assault in a child, the DNA that was 
recovered from the child’s bedding and underwear was coincident with his father 
DNA profile. Can we consider his father responsible for the sexual assault? In a 
situation like this, it is not enough to recover a DNA profile but it is also 
imperative to acknowledge its source. If no serological test were done, in court, 
the presence of DNA could be explained as a result of the presence of epithelial 
cells in the child clothing which is totally common when it comes from a sibling. 
On the other hand, if serological tests linked the DNA profile to semen it would 
be way more difficult to explain its presence there. 
Beyond the probative value that body fluids may have in a crime scene, it is 
also important to acknowledge them in order to use optimized protocols to 
conduct a reliable DNA profiling [6, 7]. For example, DNA extraction processes 
are different to blood and urine. If we conducted the protocol of blood extraction 
in urine samples, it may result in a reduced quality of the extracted DNA e enable 
any conclusive DNA profile [6, 7]. For those reasons, reliable detection and 
identification of body fluids are considered crucial step in criminal investigation.   
Apparently, it seems easy to identify body fluids such as blood (colour), 
urine (smell) or even sperm (texture) due to their specific characteristics. 
However, when dried, washed or mixed with other components, their 
identification may not be that easy [1, 5, 8]. It is important to highlight that in 
court, there is no such thing as “It seems to be sperm because it looked like it 
and have the same particular texture”, it is needed an undeniable proof that it is 
sperm. Serological tests are used in forensic biology to allow the detection and 
identification of body fluids in both native form or as a residue left at a crime 
scene [4]. Serological tests are divided in two major fields: presumptive and 
confirmatory tests [9-15]. Presumptive tests rely on methodologies that are 
sensitive and performed quickly, yet they are not specific to the body fluid. Those 
tests can only indicate if the fluids might be present and do not unequivocally 
states its presence [5, 16].  On the other hand, confirmatory tests are indeed 
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specific to the body fluid we seek to identify. As presumptive tests, confirmatory 
testing is sensitive however, it takes a lot more time to perform [5, 16]. 
Idealistically, we should have a battery of confirmatory test for all important body 
fluids in order to reliably detect and identify them.  Unfortunately, there is a large 
cluster of presumptive tests and far less number of confirmatory ones. Moreover, 
till date no confirmatory test is able to reliably differentiate blood from menstrual 
blood which is an unquestionably important body fluid in sexual crimes cases.   
 Over the last years, messenger RNA (mRNA) profiling became a target for 
body fluid identification due to its tissue specific patterns [17-19]. Still, mRNA 
susceptibility to degradation by physical or chemical factors was an 
unquestionable drawback [3]. In order to sidetrack this problem, microRNAs 
(miRNAs) surge with a real potential as a confirmatory test [20].  MiRNAs are 
small non-coding RNAs with more or less than 22 nucleotides of length that, 
combined with the RNA-induced silencing complex, seems to regulate a major 
part of human gene expression [21-23]. Their regulatory functions have been 
recognized to be responsible for several biological processes such as apoptosis, 
differentiation and proliferation but also have a significant role in pathological 
conditions [24-29]. Most importantly, their tight relationship with Argonaute 
proteins makes them much less susceptive to both biotic and abiotic factors [30]. 
In 2009, Hanson and colleagues were the first to introduce miRNA profiling for 
body fluid identification in a forensic purpose and soon enough others followed 
[31-35]. Those studies pointed out a large collection of miRNAs with potential as 
biomarker, however very few were confirmed by more than one group which 
revealed the lack of reproducibility of results [36]. Besides, when some tried to 
replicate the results of others - they failed, highlighting the lack of a standard 
workflow of methodology that would be essential for miRNA profiling reliability 
[32].    
In this report, we choose to test the identification and quantification of 
four miRNAs in both blood and urine samples obtained from 50 healthy 
individuals and study their behaviour within those body fluids, using a real-time 
PCR methodology.  
 
2- Material and methods 
 
Study population 
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We conducted a miRNA expression profiling study in 50 healthy adult 
individuals (34% males and 66% females) from North of Portugal. Our group of 
study was composed by Caucasian individuals with a mean age of 42.7 years, 
with no major pathological condition in order to erase a variable that could alter 
miRNAs expression profile.  Peripheral venous blood (6ml) and urine samples 
were collected from each subject following the obtainment of a written informed 
consent from all subjects according the Helsinki Declaration principles. 
 
miRNA extraction/purification 
 After collected the biologic samples, they were processed according the 
following experimental conditions. For urine samples, the pellet resulting from a 
20 minute centrifugation at 3000 rpm was diluted with 1X PBS (Phosphate 
buffered saline), and them centrifuged  during 15 minutes at 3000 rpm, at room 
temperature. The pellet was then stabilized with TriPure
® 
Isolation Reagent (Roche 
Applied Science) and preserved at -80ºC. For blood, the samples were centrifuged 
during 5 minutes at 2500 rpm at room temperature. We transferred fresh blood 
in a 50 mL falcon and add 1xAKE (ammonium chloride, potassium hydrogen 
phosphate and EDTA). We froze the samples during 20 minutes at -20ºC and 
afterwards centrifuged them during 10 minutes at 2500 rpm. To the pellet was 
added 1xAKE and the mixture centrifuged during 10 minutes at 2500rpm. The 
pellet was suspended with 30 ml of 1xPBS which posteriorly, was centrifuge 
during 10 minutes at 2500rpm and the resulting pellet diluted in 1ml of TriPure® 
Isolation Reagent (Roche Applied Science). In urine samples, 200µl of processed 
samples was added to 8µl of miRNA buffer and 80µl de chloroform.  The solution 
incubated 10 minutes at room temperature and centrifuged at 1200g during 15 
minutes. To the resulting upper-phase it was added 43,2 µl of absolute ethanol. 
To this point forward we handled the samples with GRS microRNA Kit (Grisp®) 
according to the manufacturer's instructions yet, we used half the volumes. The 
blood samples were handled for miRNAs extraction using the GRS microRNA Kit 
(Grisp®) according to the manufacturer's instructions.  
 
cDNA synthesis and miRNA relative quantification 
Subsequently, miRNAs previously extracted were used as a template for 
cDNA synthesis using TaqMan® MicroRNA Reverse Transcription Kit (Applied 
Biosystems®). Afterward, NanoDrop® ND-1000 was used to measure UV 
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absorbance spectra determining 260/280nm ratios in order to assess the 
quantity and quality of RNA.  
To quantify miRNA expression, real-time PCR assays were performed with a 
StepOne™ System, reactions were carried out 1X TaqMan®Universal Master Mix II 
(Applied Biosystems®), with 1X probes to amplify the  target miRNAs (Taqman 
MicroRNA Assays  miR-127: 002229, miR-221: 002096, miR-222: 002097 and 
RNU-48: 002745 and cDNA sample. 
The data analysis was carried out using the StepOne Software v2.2 (Applied 
Biosystems®) with the same baseline and threshold set for each plate, in order to 
generate threshold cycle (Ct) values for all the genes in each sample. 
 
Statistical Analysis 
Data analysis was performed by the computer software IBM®SPSS®Statistics 
(Version 22.0). In order to assess any statistical alterations in our normalized 
miRNAs expression essay we used 2
−ΔΔCt
 method along with Student's t test was 
used in order to evaluate any statistical differences in miRNA expression here 
explored. 
 
3- Results and Discussion 
3.1- Cycle threshold vs miRNA purity 
Urine samples were processed and the resulting pellet was diluted in 1ml 
of TriPure
®
 Isolation Reagent (Roche Applied Science
®
). Visually a wide range of 
pink colour was noticeable within our urine samples. Those with a deep pink were 
related with samples with a more substantial pellet unlike those with a less 
considerable pellet who presented themselves with a lighter colour. After miRNA 
extraction, we quantify miR-222 in urine samples and perceived that only few of 
them were detected. Interestingly, only the ones with a lighter colour were indeed 
detected. This tricky situation was associated with the ratio of absorbance (260 
nm/280nm) which is used to assess the purity of RNA [37]. We observed that 
lighter colour was an indicator of a high ratio, on the other hand, those with 
higher optical density had a very low ratio, far from the ratio of ~2.0 which is 
generally accepted as “pure” for RNA [37]. In order to sidetrack this situation, we 
choose a sample that has an optimal 260/280nm ratio and diluted the other 
samples to equalize its optical density with TriPure
®
 Isolation Reagent (Roche 
Applied Science
®
). Posteriorly, we choose 5 samples to test and observed a 
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considerable decrease of Ct in the samples processed with the optimized protocol 
(Fig.1). By definition the cycle threshold (Ct) is the number of cycle required for 
the fluorescent signal to overpass the threshold. Its levels decrease proportionally 
with the increase of the target in the sample [38].   
 
 
 
 
 
 
 
 
The difference of Ct value is very significant once, at each cycle, the 
amount of DNA is duplicated, demonstrating that RNA purity is clearly a factor 
that challenges miRNA profiling. As showed, miRNA quantification can present 
itself with a low concentration or can go totally undetected when 260/280nm 
ratio is low however, when optimized, miRNA concentration increased 
significantly. As said previously, different reports indicated miRNAs as 
biomarkers for human body fluids identification though, when others tried to 
replicate them, they failed. Our results show that for the same sample, different 
degrees of purity are crucial for their positive detection. There is why, RNA purity 
needed to be optimal, otherwise it may lead to unreliable results, which could 
explain, the failed attempts done by some authors when trying to replicate others 
results.  
  
3.2 – Endogenous control selection 
 In qRT-PCR, data normalization is imperatively required for relative 
quantification analysis [39-41]. The integration of an invariant endogenous -
Figure 1  - Cycle threshold vs RNA purity. This figure presents the Ct values of miR-222 taken from 5 samples processed 
with both normal and optimized protocol (first and second column respectively). It is showed that the considerable fall 
of Ct values correlates with an increase of 260/280nm ratio. 
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control, also called as reference gene, has the main purpose to correct systematic 
technical and/or experimental errors [40, 42]. Thus, we choose to use RNU-48 as 
our reference gene for the data normalization. Widely used as an endogenous 
control, RNU-48 is expected to have a stable pattern among samples [43, 44]. 
However, according our results, within our assays we didn’t observe this stable 
pattern between the samples types included in this study. As showed in figure 2, 
RNU-48 was the one with a major standard deviation, between blood and urine 
samples, when compared with the other 3 miRNAs analyzed, which make it 
inappropriate as an endogenous control for our study.  
 
 
 
 
 
 
 
 
 
 
Seemingly, we were not the only ones that concluded this variation, Sapre et al. 
also assumed that RNU-48 was inadequate as an endogenous control due to its 
systematic perturbation in its expression levels [45]. Ultimately, what we want to 
highlight is the important to define a correct normalization gene depending on 
the samples we choose to work with.  Here, we do not discredit RNU-48 as a 
normalization gene however, when it comes to urine and blood profiling it is not 
reliable for data normalization.  
 Remarkably, the unexpected miR-222 profile remained barely unaffected 
and presented no significant differences between urine and blood. miR-222 
behaviour within our samples was surprising once, it is being aimed for its 
deregulation by many other groups [46-48].  Here, it does not present any 
Figure 2 – Average Ct of both urine and blood samples for all four miRNAs considered for this report. Interestingly, 
RNU-48 – our first choice as endogenous control - is the one presenting the most considerable standard deviation. 
On the other hand, miR-222 behaves more like a reference gene once it does not present a significant change of 
profile between urine and blood.  
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variation within samples, any variation among both body fluids, it did even 
remained stable within different stages of age and do not alter with gender. 
According the literature, this particular behaviour is expected of endogenous 
controls,  thus we decided to use miR-222 as our endogenous control in order to 
normalise our data in the present study [49]. 
 
3.3 – miRNAs as body fluids biomarkers 
 Attending the behaviour of miR-222, we used it as an endogenous control 
for our data normalisation in order to analyse differences in the expression levels 
of miR-127, miR-221 and RNU-48 among blood and urine samples. 
As showed in figure 3, we can state that all miRNAs considered were 
detected at variable levels in blood and urine samples. We observed statistical 
significant higher expression levels of miR-127, miR-221 and RNU-48 in blood 
samples than in urine samples (P˂0.050). 
In table 1, we assessed the fold change in expression levels of the miRNAs 
included in the study and concluded  that miR-221 has a 4,86 fold increase in 
blood when compared to urine while miR-221 has 5,39 fold increase.  
 
Table 1 – miRNA detection in both urine and blood samples and its corresponding fold change within the body fluids. 
*ΔΔCt= ( ΔCt blood – ΔCt urine) 
 
 
 
RNU-48 is the one with a major difference between urine and blood. This miRNA 
used numerous times as an endogenous control present a 141-fold-increase 
expression in blood when compared to urine, supporting our decision to not use 
it to normalize our data.  
Currently, a minor number of miRNAs have been acknowledged as tissue specific 
- at least reliably. In the literature, miRNAs are considered tissue specific when 
they’re found with high abundance in a specific tissue while it has low or non-
existent expression in others. The definition itself is questionable, once there are 
no values that define what “high abundance” and “low-abundance” are. It is 
imperative to define a range of values to define those terms and by that, lead to 
reliable results. That differential profile patterns would allow body fluids 
identification and serve as a major confirmatory test. Considering our results, we 
can conclude that miR-127, miR-221 and RNU-48 are not suitable for neither 
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blood nor urine identification. Despite a significant difference of expression, they 
do not present the expected gap of expressional patterns to be considered as a 
good biomarker.  
 As we previously stated, the miRNAs considered as biomarkers for body 
fluid identification in other reports have been difficult to replicate. We admit that 
those difficulties are linked to several factors as environmental factors, different 
methodologies used, age, gender, pathologies among several others. We know 
that miRNAs expression levels do alter with both biotic and abiotic factors, there 
is why we try to minimize the impact of those within our samples excluding, as 
example, acute pathological conditions. Despite considering that miR-127, miR-
221 and RNU-48 are unsuitable for urine and blood identification, we wanted to 
study their expressional behavior within samples with different stages of age and 
gender. Figure 4A displays an overview of their relative quantification within 
female and male samples. Considering blood samples, we did not observe any 
statistical significant difference in miRNAs expression (P>0,050). On the other 
hand, in urine, RNU-48 presented itself with a significant overexpression in 
females (P<0,050). Once again, this overexpression presented itself as another 
drawback to the use of RNU-48 as endogenous control.  
When it comes to age, we divided our sampling in 3 age groups: 20-40, 41-
60 and over 60 years old. As it is shown in figure 4B, the sample relative 
quantification demonstrated no statistical significant differences in their 
expression profile – neither in blood nor in urine (P>0,050).  
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4 – Conclusion and future perspectives 
More than just a source of DNA, body fluids sole presence can have the 
most probative value. Hanson et al. introduced miRNA profiling as a reliable tool 
to identify body fluids such as blood, menstrual blood, semen, vaginal secretion 
and urine due to their tissue-specific pattern and stability when conditioned by 
degradation processes [18, 50].  
Here we focused our attention in four miRNAs: miR-127, miR-221, miR-222 
and RNU-48. Soon enough miRNAs purity struck our attention, when we observe 
that low value of 260/280nm ratio was associated with a poor degree of 
detection. When we upgraded our miRNA isolation protocol the consequence 
reflected in a higher success detection rate and in a considerable decrease of the 
samples Cycle threshold.   
B 
A 
Figure 3 – Relative quantification of miR-127, miR-221 and RNU-48 when conditioned by age and gender.  
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It would be irrefutably helpful to understand which threshold could affect miRNA 
profiling once, as it was shown, miRNA purity do affect considerably their relative 
quantification. It could even convey wrong outcomes once, even miRNAs with 
high concentration within body fluids can appear with low concentration or totally 
inexistent.  
Our second result emphasised the importance of an adequate endogenous 
control selection attending the study objectives. Initially, according to the 
literature, we select the RNU-48 as our endogenous control but its behaviour 
within blood and urine make us reconsider our decision. RNU-48 is usually used 
as a reference gene due to its stable behaviour within samples however, our assay 
showed otherwise. Within the miRNAs tested, RNU-48 was the one with a more 
pronounced variability within the different samples, which is opposed of what 
would be expected of an endogenous control. Unexpectedly, miR-222 presented 
itself with the lowest standard deviation between blood and urine samples. 
Additionally, we studied its expression levels and compared them within age and 
gender and concluded that no significant alteration was noticeable. As stated 
earlier, endogenous controls are indispensable to validate qRT-PCR results 
however, till date, no endogenous control is universally acknowledged. This 
problem is reflected in our case, where one of the most used as an endogenous 
control proved to be unsuitable for urine and blood miRNA analysis. This subject 
is a very sensitive point in miRNA profiling. There is why it is imperative to focus 
our future line of work towards finding a reliable normalisation gene before 
anything else.  
 In this case, we could establish that all four miRNAs have different 
expressional patterns in urine and blood. However, to be considered as a 
biomarker, a major difference within body fluids would be expected.  We 
conclude that the miRNAs analysed do not have the potential to be considered as 
a biomarker for body fluid identification.  
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6 - General conclusion and future perspectives 
 
 
“Ah, not in knowledge is happiness, but in the acquisition of knowledge! In 
forever knowing, we are forever blessed.” 
Edgar A. Poe 
 
The importance of body fluids in forensics is undeniable, however the 
methodologies used for their detection and identification are not always as 
reliable that would be expected.  Recently, miRNA profiling was introduced as a 
possible tool for their identification but very little has been done yet. Very few 
scientific reports have been published and their respective results not always 
reproducible.  
We studied an idea that took form in 2009 and scientifically speaking, five 
years is such a short time – definitely too short to bring up a reliable 
methodology.  
We proceed to a miRNA profiling study in urine and blood samples in a 
much larger sampling than used previously by other authors. We reached 
interesting conclusions namely the importance of factors that indirectly influence 
miRNA profiling within body fluids. Those results back up our previous 
statements that we published in the review article. Throughout our review, we 
were able to highlight potential variables, both biotic and abiotic, that could 
undermine miRNA full potential as a biomarker for human body-fluids 
identification. Moreover, we were able to highlight the impact of miRNA purity on 
their expressional profiling but also the impact of an adequate selection of the 
normalization gene for blood and urine identification. 
Our conclusions lead to an imperative future line of work. It would be 
crucial to do a major screening study of the expressional levels of others miRNAs 
within body fluids, but also acknowledge the implications of both biotic and 
abiotic variables in miRNA profiling. Those studies would be essential to highlight 
their still latent potential.
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